TW201710231A - Crystal of alcohol having fluorene skeleton and method for producing same - Google Patents

Crystal of alcohol having fluorene skeleton and method for producing same Download PDF

Info

Publication number
TW201710231A
TW201710231A TW105122933A TW105122933A TW201710231A TW 201710231 A TW201710231 A TW 201710231A TW 105122933 A TW105122933 A TW 105122933A TW 105122933 A TW105122933 A TW 105122933A TW 201710231 A TW201710231 A TW 201710231A
Authority
TW
Taiwan
Prior art keywords
crystal
alcohol
anthracene skeleton
weight
above formula
Prior art date
Application number
TW105122933A
Other languages
Chinese (zh)
Other versions
TWI658034B (en
Inventor
Hiroyuki Kato
Takafumi Saiki
Yuka Morinaga
Yuji Nishida
Katsuhiro Fujii
Original Assignee
Taoka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57833962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201710231(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taoka Chemical Co Ltd filed Critical Taoka Chemical Co Ltd
Publication of TW201710231A publication Critical patent/TW201710231A/en
Application granted granted Critical
Publication of TWI658034B publication Critical patent/TWI658034B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/16Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/40Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Provided are: a crystal of an alcohol having a fluorene skeleton represented by formula (1) which shows a melting endothermic peak temperature of 173-176 DEG C in differential scanning calorimetry; a crystal of an alcohol having a fluorene skeleton represented by formula (1) which shows a melting endothermic peak temperature of 190-196 DEG C; a crystal of an alcohol having a fluorene skeleton represented by formula (1) which shows a melting endothermic peak temperature of 167-170 DEG C; and a method for producing the same.

Description

具有茀骨架之醇之結晶及其製造方法 Crystal of alcohol having an anthracene skeleton and method for producing the same

本發明係關於一種適合作為形成構成光學透鏡或光學膜所代表之光學構件之樹脂(光學樹脂)的單體,且加工性、生產性優異之新穎之具有茀骨架之醇之結晶及其製造方法。 The present invention relates to a novel olefin having an anthracene skeleton which is suitable as a monomer for forming a resin (optical resin) constituting an optical member represented by an optical lens or an optical film, and which is excellent in workability and productivity, and a method for producing the same .

以具有茀骨架之醇為原料單體之聚碳酸酯、聚酯、聚丙烯酸酯、聚胺基甲酸酯、環氧樹脂等樹脂材料由於光學特性、耐熱性等優異,近年來,作為光學透鏡或光學片材等新光學材料而備受矚目。其中,具有下述式(1): A resin material such as a polycarbonate, a polyester, a polyacrylate, a polyurethane, or an epoxy resin having an anthracene skeleton as a raw material monomer is excellent in optical properties, heat resistance, etc., and has recently been used as an optical lens. Or new optical materials such as optical sheets have attracted attention. Among them, there is the following formula (1):

所表示之結構的具有苯基及茀骨架之醇及由該醇類所製造之樹脂於折射率等光學特性、耐熱性、耐水性、耐化學品性、電氣特性、機械特性、熔解性等各特性方面優異而備受矚目(例如日本專利特開平07-149881號公報(專利文獻1)、日本專利特開2001-122828號公報(專利文獻2)、日本專利特開2001-206863號公報(專利文獻3)、日本專利特開2009-256342號公報(專利文獻4))。 The alcohol having a phenyl group and an anthracene skeleton and the resin produced from the alcohol having such a structure have optical properties such as refractive index, heat resistance, water resistance, chemical resistance, electrical properties, mechanical properties, and meltability. (Japanese Patent Laid-Open No. Hei 07-149881 (Patent Document 1), Japanese Patent Laid-Open No. 2001-122828 (Patent Document 2), and Japanese Patent Laid-Open Publication No. 2001-206863 (Patent No.) Document 3), Japanese Patent Laid-Open Publication No. 2009-256342 (Patent Document 4)).

作為上述式(1)所表示之具有茀骨架之醇之製造方法,已知有於鹼性觸媒之存在下,使下述式(2): The method for producing an alcohol having an anthracene skeleton represented by the above formula (1) is known to have the following formula (2) in the presence of a basic catalyst:

所表示之具有茀骨架之酚化合物與環氧乙烷進行反應(專利文獻2)之方法。然而,藉由本方法所獲得之上述式(1)所表示之具有茀骨架之醇之純度較低,會大量地副生成環氧乙烷與3、4分子加成而成之化合物,而難以高純度地獲得上述式(1)所表示之具有茀骨架之醇。 The method of reacting a phenol compound having an anthracene skeleton with ethylene oxide (Patent Document 2). However, the purity of the alcohol having an anthracene skeleton represented by the above formula (1) obtained by the present method is low, and a large amount of a compound of ethylene oxide and 3 or 4 molecules is added in a by-product, which is difficult to be high. The alcohol having an anthracene skeleton represented by the above formula (1) is obtained in a pure manner.

另一方面,作為改善專利文獻2所記載之製法之方法,揭示有於酸觸媒及硫醇類之存在下,使下述式(3): On the other hand, as a method for improving the production method described in Patent Document 2, it is revealed that the following formula (3) is obtained in the presence of an acid catalyst and a mercaptan:

所表示之醇類與9-茀酮進行反應,而獲得上述式(1)所表示之具有茀骨架之醇之方法(專利文獻3、4)。然而,專利文獻4中記載有如下主旨:若藉由專利文獻3所記載之方法而製造上述式(1)所表示之具有茀骨架之醇,則根據光學用途等、用途,而會有尤其欲避免之著色,進而該著色即使實施純化操作亦無法去除。 A method in which the alcohol represented by the reaction is reacted with 9-fluorenone to obtain an alcohol having an anthracene skeleton represented by the above formula (1) (Patent Documents 3 and 4). However, Patent Document 4 discloses that the alcohol having an anthracene skeleton represented by the above formula (1) is produced by the method described in Patent Document 3, and it is particularly desirable depending on the use of the optical application or the like. The coloring is avoided, and the coloring cannot be removed even if a purification operation is performed.

又,專利文獻4中揭示有以下之方法:以改善專利文獻2及3中所記載之製造方法為目的,於相對於酸觸媒及9-茀酮類100重量份存在硫醇類3重量份以上之條件下,使上述式(3)所表示之醇類與9-茀酮進行反應,而獲得上述式(1)所表示之具有茀骨架之醇。然而,雖然藉由該方法所獲得之上述式(1)所表示之具有茀骨架之醇之著色較少於藉由專利文獻3之方法所獲得者,但其著色改善並不充分。又,反應 時需要大量之硫醇類,因此難以自上述式(1)所表示之具有茀骨架之醇完全去除硫醇類,於將該醇用作樹脂原料時,存在源自硫醇類之硫成分引起樹脂之進一步著色之問題。 Further, Patent Document 4 discloses a method of improving the production methods described in Patent Documents 2 and 3 by presenting 3 parts by weight of a thiol with respect to 100 parts by weight of an acid catalyst and 9-fluorenone. Under the above conditions, the alcohol represented by the above formula (3) is reacted with 9-fluorenone to obtain an alcohol having an anthracene skeleton represented by the above formula (1). However, although the color of the alcohol having an anthracene skeleton represented by the above formula (1) obtained by the method is less than that obtained by the method of Patent Document 3, the improvement in coloring is not sufficient. Again, the reaction When a large amount of mercaptans are required, it is difficult to completely remove the mercaptans from the alcohol having an anthracene skeleton represented by the above formula (1), and when the alcohol is used as a resin raw material, there is a sulfur component derived from mercaptans. The problem of further coloration of the resin.

進而,本案發明者等人對上述專利文獻2~4所記載之方法進行追加試驗,發現採用專利文獻3所記載之方法時,反應不進行,或者即使反應進行,亦僅獲得包含上述式(1)所表示之具有茀骨架之醇的油狀物,而未獲得結晶狀之上述式(1)所表示之具有茀骨架之醇。另一方面,於專利文獻2及4之追加試驗中,雖然獲得結晶狀之上述式(1)所表示之具有茀骨架之醇,但反應或反應後之取出操作(晶析操作)所使用之溶劑(芳香族烴類)被包藏於上述式(1)所表示之具有茀骨架之醇中,而成為包藏體。 Furthermore, the inventors of the present invention conducted additional tests on the methods described in Patent Documents 2 to 4, and found that when the method described in Patent Document 3 is used, the reaction does not proceed, or even if the reaction proceeds, only the above formula (1) is obtained. An oil having an alcohol having an anthracene skeleton, and an alcohol having an anthracene skeleton represented by the above formula (1) in a crystalline form is not obtained. On the other hand, in the additional tests of Patent Documents 2 and 4, an alcohol having an anthracene skeleton represented by the above formula (1) in a crystalline form is obtained, but the extraction operation (crystallization operation) after the reaction or the reaction is used. The solvent (aromatic hydrocarbon) is contained in the alcohol having an anthracene skeleton represented by the above formula (1) to form an inclusion.

[先前技術文獻] [Previous Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本專利特開平07-149881號公報 [Patent Document 1] Japanese Patent Laid-Open No. Hei 07-149881

[專利文獻2]日本專利特開2001-122828號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2001-122828

[專利文獻3]日本專利特開2001-206863號公報 [Patent Document 3] Japanese Patent Laid-Open Publication No. 2001-206863

[專利文獻4]日本專利特開2009-256342號公報 [Patent Document 4] Japanese Patent Laid-Open Publication No. 2009-256342

本發明之目的在於提供一種高純度且著色較少、進而並非包藏體之上述式(1)所表示之具有茀骨架之醇之結晶。 An object of the present invention is to provide a crystal of an alcohol having an anthracene skeleton represented by the above formula (1) which is high in purity and which is less colored and which is not an inclusion body.

本發明者等人為了解決上述問題而反覆進行努力研究,結果發現:藉由在碳數為4以上之鏈狀酮類之存在下,使上述式(2)所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液後,由上述反應液而製備含有 碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液,於特定溫度範圍內使結晶自該晶析溶液析出,並將析出之結晶分離,而能夠提供高純度、低著色、且並非包藏體之上述式(1)所表示之具有茀骨架之醇。具體而言,包括以下之發明。 In order to solve the above problems, the inventors of the present invention have conducted intensive studies and found that the phenolic compound having an anthracene skeleton represented by the above formula (2) is present in the presence of a chain ketone having 4 or more carbon atoms. After reacting with ethylene carbonate to obtain a reaction liquid containing the alcohol having an anthracene skeleton represented by the above formula (1), the reaction liquid is prepared from the above reaction liquid. a crystallization solution having a carbon number of 4 or more chain ketones and a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight, and crystals are precipitated from the crystallization solution in a specific temperature range, and precipitated The crystals are separated, and it is possible to provide an alcohol having an anthracene skeleton represented by the above formula (1) which is high in purity, low in coloration, and which is not an inclusion body. Specifically, the following inventions are included.

〔1〕 〔1〕

一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為173~176℃的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 173 to 176 ° C obtained by differential scanning calorimetry analysis,

〔2〕 〔2〕

一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=7.7±0.2°、17.2±0.2°、18.3±0.2°、19.6±0.2°、20.8±0.2°及21.4±0.2°處具有波峰之下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=7.7±0.2°, 17.2±0.2°, 18.3±0.2°, 19.6. The following formula (1) having a peak at ±0.2°, 20.8±0.2°, and 21.4±0.2°,

〔3〕 [3]

一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為190~196℃的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 190 to 196 ° C obtained by differential scanning calorimetry analysis,

[化6] [Chemical 6]

〔4〕 [4]

一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=14.9±0.2°、17.8±0.2°、18.9±0.2°、19.7±0.2°、20.0±0.2°及21.0±0.2°處具有波峰之下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=14.9±0.2°, 17.8±0.2°, 18.9±0.2°, 19.7 The following formula (1) having a peak at ±0.2°, 20.0±0.2°, and 21.0±0.2°,

〔5〕 [5]

一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為167~170℃的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 167 to 170 ° C obtained by differential scanning calorimetry analysis,

〔6〕 [6]

一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=9.8±0.2°、14.9±0.2°、17.6±0.2°、18.8±0.2°、19.4±0.2°、20.0±0.2及20.6±0.2°處具有波峰之下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=9.8±0.2°, 14.9±0.2°, 17.6±0.2°, 18.8. ±0.2°, 19.4±0.2°, 20.0±0.2, and 20.6±0.2°, which are represented by the following formula (1) having a peak,

[化9] [Chemistry 9]

〔7〕 [7]

一種具有茀骨架之醇之結晶,其係於167~176℃之範圍內具有至少一個藉由示差掃描熱量分析所獲得之吸熱波峰的下述式(1)所表示者, a crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having at least one endothermic peak obtained by differential scanning calorimetry in the range of 167 to 176 ° C,

〔8〕 〔8〕

一種如〔1〕至〔7〕中任一項之具有茀骨架之醇之結晶,其並非包藏體。 A crystal of an alcohol having an anthracene skeleton according to any one of [1] to [7], which is not an inclusion body.

〔9〕 〔9〕

如〔1〕至〔8〕中任一項之具有茀骨架之醇之結晶,其中使上述式(1)所表示之具有茀骨架之醇12g溶解至純度99重量%以上之N,N-二甲基甲醯胺30ml中而成之溶液之黃度(YI值)為10以下。 The crystal of an alcohol having an anthracene skeleton according to any one of [1] to [8], wherein 12 g of the alcohol having an anthracene skeleton represented by the above formula (1) is dissolved to a purity of 99% by weight or more of N, N-di The yellowness (YI value) of the solution of methylmethamine in 30 ml is 10 or less.

〔10〕 [10]

如〔1〕至〔9〕中任一項之具有茀骨架之醇之結晶,其中芳香族烴類之含量為1重量%以下。 The crystal of an alcohol having an anthracene skeleton according to any one of [1] to [9], wherein the content of the aromatic hydrocarbon is 1% by weight or less.

〔11〕 [11]

一種如〔1〕或〔2〕之具有茀骨架之醇之製造方法,其依序包括下述(a)至(c)之步驟: A method for producing an alcohol having an anthracene skeleton according to [1] or [2], which comprises the following steps (a) to (c) in sequence:

(a) (a)

於碳數為4以上之鏈狀酮類之存在下,使下述式(2): In the presence of a chain ketone having a carbon number of 4 or more, the following formula (2) is caused:

所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟; a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1);

(b) (b)

由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟; a step of preparing a crystallization solution containing a chain ketone having 4 or more carbon atoms and having a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight;

(c) (c)

於75~85℃下使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟。 A step of separating crystals from the above crystallization solution at 75 to 85 ° C and separating the precipitated crystals.

〔12〕 [12]

一種如〔3〕或〔4〕之具有茀骨架之醇之製造方法,其依序包括下述(d)至(f)之步驟: A method for producing an alcohol having an anthracene skeleton according to [3] or [4], which comprises the following steps (d) to (f) in sequence:

(d) (d)

於碳數為4以上之鏈狀酮類之存在下,使下述式(2): In the presence of a chain ketone having a carbon number of 4 or more, the following formula (2) is caused:

所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟; a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1);

(e) (e)

由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟; a step of preparing a crystallization solution containing a chain ketone having 4 or more carbon atoms and having a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight;

(f) (f)

於90~100℃下使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟。 A step of separating crystals from the above crystallization solution at 90 to 100 ° C and separating the precipitated crystals.

〔13〕 [13]

一種如〔5〕或〔6〕之具有茀骨架之醇之製造方法,其依序包括下述(g)至(i)之步驟: A method for producing an alcohol having an anthracene skeleton according to [5] or [6], which comprises the following steps (g) to (i) in sequence:

(g) (g)

於碳數為4以上之鏈狀酮類之存在下,使下述式(2): In the presence of a chain ketone having a carbon number of 4 or more, the following formula (2) is caused:

所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟; a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1);

(h) (h)

由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟; a step of preparing a crystallization solution containing a chain ketone having 4 or more carbon atoms and having a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight;

(i) (i)

於70℃以下使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟。 The step of precipitating crystals from the above crystallization solution at 70 ° C or lower and separating the precipitated crystals.

根據本發明,可提供一種高純度且著色較少、進而並非包藏體之上述式(1)所表示之具有茀骨架之醇之結晶。 According to the present invention, it is possible to provide a crystal of an alcohol having an anthracene skeleton represented by the above formula (1) which is high in purity and which is less colored and which is not an inclusion body.

尤其是,於上述式(1)所表示之具有茀骨架之醇之結晶為包藏體之情形時,對於該包藏體,使丙烯酸等與之反應而製成其他化合物時,存在包藏體所包藏之化合物(以下,亦有稱為客體分子之情形)阻礙反應,根據反應而無法使用之問題,又,於直接進行熔融等而用作樹脂原料時,亦存在如下情況:需要將源自熔融過程中產生之客體分子之蒸氣去除至系外,或於客體分子之影響下引起所獲得之樹脂之品質變得不固定之問題。進而,由於能夠包藏燃燒點較低之客體分子(於上述引用例之情形時為芳香族烴類),故而於保管或輸送上述式(1)所表示之具有茀骨架之醇時,亦有變得易於引起火災之防災方面之擔憂。 In particular, when the crystal of the alcohol having an anthracene skeleton represented by the above formula (1) is an inclusion body, when the acrylic acid or the like is reacted with the inclusion body to form another compound, the inclusion body is contained. The compound (hereinafter, also referred to as a guest molecule) hinders the reaction, and cannot be used depending on the reaction. When it is directly used for melting or the like as a resin raw material, there is also a case where it is required to be derived from the melting process. The vapor of the generated guest molecule is removed to the outside of the system, or the effect of the guest molecule causes the quality of the obtained resin to become unfixed. Further, since it is possible to store a guest molecule having a low burning point (an aromatic hydrocarbon in the case of the above-mentioned cited example), it is also changed when the alcohol having an anthracene skeleton represented by the above formula (1) is stored or transported. It is easy to cause fire disaster prevention concerns.

然而,如上所述,於欲基於公知方法而獲得上述式(1)所表示之具有茀骨架之醇作為結晶之情形時,尚未知曉獲得作為包藏有客體分子之包藏體,而獲得並非包藏體之上述式(1)所表示之具有茀骨架之醇之結晶的方法。另一方面,包藏體中所含之客體分子難以藉由在客體分子之沸點以上之溫度下使結晶乾燥之通常實施之方法而去除,暫時將結晶加熱至熔點以上並使之熔融後將客體分子去除等於工業上難以實施,或者必須採用非常耗費成本之方法,因此發現了並非包藏體之上述式(1)所表示之具有茀骨架之醇之結晶及其製造方法,可認為發現了上述情況之本發明尤其於工業規模上製造、使用上述式(1)所表示之具有茀骨架之醇之結晶時非常有意義者。 However, as described above, when an alcohol having an anthracene skeleton represented by the above formula (1) is obtained as a crystal based on a known method, it is not known that an entrapped body as a guest molecule is obtained, and a non-occluded body is obtained. A method of crystals of an alcohol having an anthracene skeleton represented by the above formula (1). On the other hand, it is difficult to remove the guest molecule contained in the inclusion by a usual method of drying the crystal at a temperature higher than the boiling point of the guest molecule, and temporarily heating the crystal to a melting point or higher and melting the guest molecule. The removal is equivalent to industrially difficult to implement, or it is necessary to adopt a very costly method. Therefore, it has been found that the crystal of the alcohol having an anthracene skeleton represented by the above formula (1) which is not the inclusion body and a method for producing the same are found. The present invention is particularly useful in the production and use of a crystal of an alcohol having an anthracene skeleton represented by the above formula (1) on an industrial scale.

圖1係表示實施例1所獲得之結晶(結晶B)之示差掃描熱量測定(DSC,Differential Scanning Calorimetry)曲線的圖。 Fig. 1 is a graph showing a differential scanning calorimetry (DSC) curve of crystals (crystal B) obtained in Example 1.

圖2係表示實施例2所獲得之結晶(結晶C)之示差掃描熱量測定(DSC)曲線的圖。 Fig. 2 is a graph showing a differential scanning calorimetry (DSC) curve of the crystal (crystal C) obtained in Example 2.

圖3係表示比較例1所獲得之結晶(結晶A)之示差掃描熱量測定 (DSC)曲線的圖。 Figure 3 is a graph showing the differential scanning calorimetry of the crystal (crystal A) obtained in Comparative Example 1. A diagram of the (DSC) curve.

圖4係表示實施例1所獲得之結晶(結晶B)之粉末X線繞射圖譜的圖。 Fig. 4 is a view showing a powder X-ray diffraction pattern of the crystal (crystal B) obtained in Example 1.

圖5係表示實施例2所獲得之結晶(結晶C)之粉末X線繞射圖譜的圖。 Fig. 5 is a view showing a powder X-ray diffraction pattern of the crystal (crystal C) obtained in Example 2.

圖6係表示比較例1所獲得之結晶(結晶A)之粉末X線繞射圖譜的圖。 Fig. 6 is a view showing a powder X-ray diffraction pattern of the crystal (crystal A) obtained in Comparative Example 1.

圖7係比較例1所獲得之結晶(結晶A)之TG-DTA線圖。 Fig. 7 is a TG-DTA chart of the crystal (crystal A) obtained in Comparative Example 1.

圖8係比較例2所獲得之結晶之TG-DTA線圖。 Fig. 8 is a TG-DTA line diagram of the crystal obtained in Comparative Example 2.

圖9係表示實施例4所獲得之結晶(結晶D)之示差掃描熱量測定(DSC)曲線的圖。 Fig. 9 is a graph showing a differential scanning calorimetry (DSC) curve of the crystal (crystal D) obtained in Example 4.

圖10係表示實施例4所獲得之結晶(結晶D)之粉末X線繞射圖譜的圖。 Fig. 10 is a view showing a powder X-ray diffraction pattern of the crystal (crystal D) obtained in Example 4.

<上述式(1)所表示之具有茀骨架之醇之結晶> <Crystal of an alcohol having an anthracene skeleton represented by the above formula (1)>

本發明之上述式(1)所表示之具有茀骨架之醇之結晶(以下,亦有稱為本發明之結晶之情形)具有藉由示差掃描熱量分析(DSC)所獲得之熔解吸熱最大溫度、及粉末X線繞射圖譜中之繞射角2θ之至少一個特徵。 The crystal of the alcohol having an anthracene skeleton represented by the above formula (1) of the present invention (hereinafter, also referred to as the crystal of the present invention) has a melting endothermic maximum temperature obtained by differential scanning calorimetry (DSC), And at least one characteristic of a diffraction angle 2θ in the powder X-ray diffraction pattern.

本發明之結晶可根據藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度而區分為3種結晶。具體為該熔解吸熱最大溫度為173~176℃者(以下亦有稱為結晶B之情形)、為190~196℃者(以下亦有稱為結晶C之情形)、及為167~170℃者(以下亦有稱為結晶D之情形)。再者,公知之上述式(1)所表示之具有茀骨架之醇之包藏體(包藏有芳香族烴類作為客體分子之包藏體;以下亦有稱為結晶A之情形)之藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為125~147℃。 The crystal of the present invention can be classified into three kinds of crystals according to the maximum temperature of melting endotherm obtained by differential scanning calorimetry. Specifically, the melting endothermic maximum temperature is 173 to 176 ° C (hereinafter referred to as crystallization B), 190 to 196 ° C (hereinafter also referred to as crystallization C), and 167 to 170 ° C (There is also a case called crystal D below). Further, it is known that the inclusion of an alcohol having an anthracene skeleton represented by the above formula (1) (an inclusion of an aromatic hydrocarbon as a guest molecule; and hereinafter referred to as a crystal A) is subjected to differential scanning. The maximum temperature of melting endothermic obtained by thermal analysis is 125~147 °C.

又,有獲得結晶B及D之混合結晶之情形,該混合結晶於167~176℃之範圍內具有至少一個藉由示差掃描熱量分析所獲得之吸熱波峰。再者,即使為結晶B及D之混合結晶,亦可成為高純度且著色較少、進而並非包藏體之具有與下述本發明之結晶之特徵相同之特徵的結晶。 Further, in the case where a mixed crystal of crystals B and D is obtained, the mixed crystal has at least one endothermic peak obtained by differential scanning calorimetry in the range of 167 to 176 °C. Further, even in the case of the mixed crystals of the crystals B and D, it is possible to obtain a crystal having high purity and less coloration, and further, not the inclusion body, having the same characteristics as those of the crystal of the present invention described below.

本發明中所謂藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度係指於下述條件下實施示差掃描熱量分析時所觀測到之最大吸熱波峰之溫度。再者,本發明之結晶所顯示之熔解吸熱最大溫度有時會因若干因素而上下變動。作為與此種偏差相關之因素,有實施分析時之試樣之加熱速度、試樣量、所使用之校正標準、設備之校正方法、分析環境之相對濕度及試樣之化學純度。對所提供之試樣進行觀察而獲得之熔解吸熱最大溫度有時根據每個裝置而不同,但一般只要恰當地校正裝置,則成為本案所定義之範圍內。 The maximum temperature of melting endotherm obtained by differential scanning calorimetry in the present invention means the temperature of the maximum endothermic peak observed when performing differential scanning calorimetry under the following conditions. Further, the melting endothermic maximum temperature shown by the crystal of the present invention sometimes fluctuates up and down due to a number of factors. As factors related to such deviation, there are the heating rate of the sample, the amount of the sample, the calibration standard used, the calibration method of the apparatus, the relative humidity of the analysis environment, and the chemical purity of the sample. The maximum temperature of the melting endotherm obtained by observing the supplied sample may vary depending on each device, but generally, as long as the device is properly calibrated, it is within the scope defined by the present invention.

本發明之結晶內,結晶B於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=7.7±0.2°、17.2±0.2°、18.3±0.2°、19.6±0.2°、20.8±0.2°及21.4±0.2°處具有特徵性波峰。結晶C於繞射角2θ=14.9±0.2°、17.8±0.2°、18.9±0.2°、19.7±0.2°、20.0±0.2°及21.0±0.2°處具有特徵性波峰。結晶D於繞射角2θ=9.8±0.2°、14.9±0.2°、17.6±0.2°、18.8±0.2°、19.4±0.2°、20.0±0.2及20.6±0.2°處具有特徵性波峰。另一方面,公知之結晶A於繞射角2θ=7.6±0.2°、15.6±0.2°、16.4±0.2°、18.7±0.2°、19.0±0.2°、20.5±0.2°及23.6±0.2°處具有特徵性波峰。 In the crystal of the present invention, the crystal B is in the powder X-ray diffraction pattern obtained by the Cu-Kα line at the diffraction angles 2θ=7.7±0.2°, 17.2±0.2°, 18.3±0.2°, 19.6±0.2°. Characteristic peaks at 20.8±0.2° and 21.4±0.2°. Crystalline C has characteristic peaks at diffraction angles 2θ=14.9±0.2°, 17.8±0.2°, 18.9±0.2°, 19.7±0.2°, 20.0±0.2°, and 21.0±0.2°. Crystalline D has characteristic peaks at diffraction angles 2θ=9.8±0.2°, 14.9±0.2°, 17.6±0.2°, 18.8±0.2°, 19.4±0.2°, 20.0±0.2, and 20.6±0.2°. On the other hand, the known crystal A has a diffraction angle of 2θ=7.6±0.2°, 15.6±0.2°, 16.4±0.2°, 18.7±0.2°, 19.0±0.2°, 20.5±0.2°, and 23.6±0.2°. Characteristic peaks.

關於本發明之結晶之純度,藉由下述方法所確定之HPLC(High Performance Liquid Chromatography,高效液相層析法)純度通常為90%以上,較佳為95%以上,更佳為98%以上。又,結晶B之鬆密度為0.2~0.5g/cm3,結晶C之鬆密度為0.6~0.8g/cm3,結晶D之鬆密度為 0.4~0.6g/cm3。另一方面,公知之結晶A之鬆密度為0.2~0.4g/cm3。如此,於本發明之結晶中,結晶C由於相對於公知之結晶A可見1.5~4倍之鬆密度之改善,故而於本發明之結晶中,結晶C於製造該結晶時當然亦可於輸送、保管、使用時大幅度改善容積效率。鬆密度係例如使用稱為粉末測試機之粉體特性評價裝置而測定,或可藉由將本發明之結晶之結晶放入量筒中,由放入特定體積時之重量算出而進行測定。 Regarding the purity of the crystal of the present invention, the HPLC (High Performance Liquid Chromatography) purity determined by the following method is usually 90% or more, preferably 95% or more, more preferably 98% or more. . Further, the bulk density of the crystal B is 0.2 to 0.5 g/cm 3 , the bulk density of the crystal C is 0.6 to 0.8 g/cm 3 , and the bulk density of the crystal D is 0.4 to 0.6 g/cm 3 . On the other hand, the known density of crystal A is 0.2 to 0.4 g/cm 3 . Thus, in the crystal of the present invention, the crystal C is improved by 1.5 to 4 times the bulk density with respect to the known crystal A. Therefore, in the crystal of the present invention, the crystal C can of course be transported during the production of the crystal. Significantly improve volumetric efficiency during storage and use. The bulk density is measured, for example, by using a powder property evaluation device called a powder tester, or can be measured by putting the crystal of the crystal of the present invention into a graduated cylinder and calculating the weight when it is placed in a specific volume.

又,本發明之結晶藉由下述方法所測得之YI值通常為10以下,較佳為7以下。另一方面,公知之結晶A通常為30以上。因此,本發明之結晶可適宜地用於尤其是光學用途等著色會成為問題之領域。 Further, the YI value of the crystal of the present invention measured by the following method is usually 10 or less, preferably 7 or less. On the other hand, the known crystal A is usually 30 or more. Therefore, the crystal of the present invention can be suitably used in the field where coloring such as optical use is a problem.

進而,本發明之結晶可具有並非包藏體之(未包藏客體分子)特徵。因此,公知之結晶A中之芳香族烴類之含量為3~6重量%,相對於此,本發明之結晶中所含之芳香族烴類之含量通常可設為1重量%以下,較佳為可設為0.5重量%以下,進而較佳為可設為0.1重量%以下。又,由於未包藏其他有機化合物,故而可將101.3kPa條件下之沸點為150℃以下之有機溶劑之含量設為通常1重量%以下,較佳為設為0.5重量%以下,進而較佳為設為0.1重量%以下。因此,於保管或輸送上述式(1)所表示之具有茀骨架之醇時,可降低變得易發生火災之防災方面之擔憂,因此當然適宜用作聚碳酸酯、聚酯、聚丙烯酸酯、聚胺基甲酸酯、環氧樹脂等樹脂材料,此外亦可適宜地用作所包藏之客體分子成為問題之領域、例如醫藥農藥用之原料(中間體)。 Further, the crystal of the present invention may have characteristics that are not occluded (no guest molecules are included). Therefore, the content of the aromatic hydrocarbons in the crystal A is 3% by weight to 6% by weight, and the content of the aromatic hydrocarbons contained in the crystal of the present invention is usually 1% by weight or less. It can be set to 0.5% by weight or less, and more preferably 0.1% by weight or less. Further, since the organic compound is not contained, the content of the organic solvent having a boiling point of 150 ° C or less under the condition of 101.3 kPa can be usually 1% by weight or less, preferably 0.5% by weight or less, and more preferably It is 0.1% by weight or less. Therefore, when the alcohol having an anthracene skeleton represented by the above formula (1) is stored or transported, the fear of occurrence of fire prevention can be reduced, and therefore it is of course suitable for use as polycarbonate, polyester, polyacrylate, A resin material such as a polyurethane or an epoxy resin can be suitably used as a raw material in which a occluded guest molecule is a problem, for example, a raw material (intermediate) for pharmaceutical and agricultural chemicals.

是否為包藏體除了可藉由例如TG-DTA(示差熱-熱重量同時測定)分析、X線解析、NMR分析之方法而判斷,此外亦可藉由在將所獲得之結晶充分乾燥至客體分子之沸點以上之條件下無重量變化之程度後,將所獲得之結晶溶解至溶劑中,並使用氣相層析法或高速液體層析法進行分析,並根據是否存在屬於客體分子之波峰而判斷。又,於 使用上述TG-DTA分析之方法中,可測定使測定樣品以一定速度進行升溫時之重量變化、與此所伴隨之吸熱、發熱行為,亦可於同時觀測到重量變化與吸熱(或發熱)之時間點判斷是否放出客體分子。 Whether or not the inclusion body can be judged by, for example, TG-DTA (differential thermo-thermal weight simultaneous measurement) analysis, X-ray analysis, NMR analysis, or by sufficiently drying the obtained crystal to the guest molecule After the degree of no change in weight above the boiling point, the obtained crystal is dissolved in a solvent, and analyzed by gas chromatography or high-speed liquid chromatography, and judged based on the presence or absence of a peak belonging to the guest molecule. . Again, in In the method of the TG-DTA analysis described above, it is possible to measure the change in weight when the sample is heated at a constant rate, and the heat absorption and heat generation behavior accompanying the measurement, and it is also possible to simultaneously observe the weight change and the heat absorption (or heat generation). At the time, it is judged whether or not the guest molecule is released.

<上述式(1)所表示之具有茀骨架之醇之製造方法> <Method for Producing Alcohol Having An Anthracene skeleton represented by the above formula (1)>

本發明之結晶係藉由經過以下之步驟而獲得:於碳數為4以上之鏈狀酮類之存在下,使上述式(2)所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇之反應液的步驟(以下,亦有稱為反應步驟之情形);由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟(以下,亦有稱為晶析溶液製備步驟之情形);及於特定溫度範圍內使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟(以下,亦有稱為晶析步驟之情形)。以下,詳述各步驟。 The crystal of the present invention is obtained by subjecting a phenol compound having an anthracene skeleton represented by the above formula (2) to ethylene carbonate in the presence of a chain ketone having 4 or more carbon atoms in the presence of a chain ketone having 4 or more carbon atoms. a step of obtaining a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1) (hereinafter, also referred to as a reaction step); and preparing a chain having a carbon number of 4 or more from the above reaction liquid a ketone-based step of arranging a total amount of aromatic hydrocarbons and cyclic ketones of less than 10% by weight (hereinafter, also referred to as a crystallization solution preparation step); and in a specific temperature range A step in which crystals are precipitated from the above crystallization solution and the precipitated crystals are separated (hereinafter, also referred to as a crystallization step). Hereinafter, each step will be described in detail.

<反應步驟> <Reaction step>

反應步驟中所使用之上述式(2)所表示之具有茀骨架之酚化合物可使用市售品,又,亦可於酸觸媒之存在下使茀酮與2-苯基苯酚進行反應而製造。 The phenol compound having an anthracene skeleton represented by the above formula (2) used in the reaction step may be a commercially available product, or may be produced by reacting an anthrone with 2-phenylphenol in the presence of an acid catalyst. .

作為反應步驟中所使用之碳數為4以上之鏈狀酮類,例如可列舉:甲基乙基酮、甲基異丁基酮、甲基異戊基酮、2-庚酮、2-辛酮、二異丁基酮等。藉由使用碳數為4以上之鏈狀酮類,可獲得充分之反應速度,而於工業上有利地獲得上述式(1)所表示之具有茀骨架之醇。再者,於使用碳數未達4之酮類之情形時,反應不進行,或即使進行反應速度亦非常慢,又,於使用環狀酮之情形時,反應雖然進行,但環狀酮類被包藏而成為包藏體,因此難以獲得並非包藏體之上述式(1)所表示之具有茀骨架之醇。 Examples of the chain ketone having 4 or more carbon atoms used in the reaction step include methyl ethyl ketone, methyl isobutyl ketone, methyl isoamyl ketone, 2-heptanone, and 2-octyl group. Ketone, diisobutyl ketone, and the like. By using a chain ketone having a carbon number of 4 or more, a sufficient reaction rate can be obtained, and an alcohol having an anthracene skeleton represented by the above formula (1) can be industrially advantageously obtained. Further, in the case of using a ketone having a carbon number of less than 4, the reaction does not proceed, or the reaction rate is very slow, and in the case of using a cyclic ketone, although the reaction proceeds, the cyclic ketone is carried out. Since it is occluded to form an occlusion body, it is difficult to obtain an alcohol having an anthracene skeleton represented by the above formula (1) which is not an occlusion body.

碳數為4以上之鏈狀酮類之使用量相對於上述式(2)所表示之具有 茀骨架之酚化合物1重量倍,通常為0.1~5重量倍,較佳為0.5~3重量倍。該等碳數為4以上之鏈狀酮類可使用1種,或者視需要將2種以上混合而使用。 The amount of the chain ketone having a carbon number of 4 or more is represented by the formula (2) The phenolic compound of the anthracene skeleton is 1 part by weight, usually 0.1 to 5 times by weight, preferably 0.5 to 3 times by weight. These chain ketones having a carbon number of 4 or more may be used alone or in combination of two or more kinds as needed.

於實施反應步驟時,除了碳數為4以上之鏈狀酮類以外,亦可併用芳香族烴類、環狀酮類以外之其他有機溶劑。於併用芳香族烴類及環狀酮類之情形時,於實施晶析步驟前,需去除芳香族烴類及環狀酮類,但由於上述式(1)所表示之具有茀骨架之醇中容易包藏芳香族烴類或環狀酮類,故而其之去除較困難,結果所獲得之結晶容易成為包藏有芳香族烴類或環狀酮類之結晶,變得難以獲得本發明之結晶。 In the reaction step, in addition to the chain ketone having 4 or more carbon atoms, an organic solvent other than the aromatic hydrocarbon or the cyclic ketone may be used in combination. In the case where aromatic hydrocarbons and cyclic ketones are used in combination, the aromatic hydrocarbons and the cyclic ketones are removed before the crystallization step, but the alcohol having an anthracene skeleton represented by the above formula (1) Since the aromatic hydrocarbons or the cyclic ketones are easily contained, it is difficult to remove them, and as a result, the crystals obtained are likely to be crystals in which aromatic hydrocarbons or cyclic ketones are contained, and it becomes difficult to obtain the crystal of the present invention.

作為本發明中可併用之芳香族炭化水類及環狀酮類以外之溶劑,可為對於上述式(2)所表示之具有茀骨架之酚化合物及碳酸乙二酯為非活性者,作為此種有機溶劑,可例示:脂肪族烴類、鹵化脂肪族烴類、醚類、二醇二醚類、酯類、脂肪族腈類、醯胺類、亞碸類等。更具體而言,作為脂肪族烴,可例示戊烷、己烷、庚烷等,作為鹵化脂肪族烴類,可例示二氯甲烷、1,2-二氯乙烷,作為醚類,可例示二異丙基醚、甲基第三丁基醚、環戊基甲基醚、二苯基醚等,作為二醇二醚類,可例示二乙二醇二甲醚、三乙二醇二甲醚、三乙二醇二丁醚等,作為酯類,可例示乙酸乙酯、乙酸丁酯等,作為脂肪族腈類,可例示乙腈等,作為醯胺類,可例示二甲基甲醯胺、二甲基乙醯胺等,作為亞碸類,可例示二甲基亞碸等。該等可併用之有機溶劑中,就取得性或操作性、及反應性良好之方面而言,適宜使用101.3kPa之條件下之沸點為80℃以上之醚類或二醇二醚類。該等有機溶劑可使用1種,或者視需要將2種以上混合而使用。該等有機溶劑之使用量相對於上述式(2)所表示之具有茀骨架之酚化合物1重量倍,通常為0.1~5重量倍,較佳為0.5~3重量倍。 The solvent other than the aromatic carbonized water and the cyclic ketone which can be used in combination in the present invention may be inactive to the phenol compound having an anthracene skeleton represented by the above formula (2) and ethylene carbonate. Examples of the organic solvent include aliphatic hydrocarbons, halogenated aliphatic hydrocarbons, ethers, glycol diethers, esters, aliphatic nitriles, guanamines, and anthraquinones. More specifically, examples of the aliphatic hydrocarbons include pentane, hexane, and heptane. Examples of the halogenated aliphatic hydrocarbons include dichloromethane and 1,2-dichloroethane. Examples of the ethers include ethers. Diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether, diphenyl ether, etc., as glycol diethers, diethylene glycol dimethyl ether, triethylene glycol diethylene glycol Examples of the esters include ethyl acetate and butyl acetate. Examples of the esters include acetonitrile and the like. Examples of the guanamines include dimethylformamide. And dimethylacetamide, etc., as an anthraquinone, a dimethyl hydrazine, etc. are illustrated. Among these organic solvents which can be used in combination, an ether or a glycol diether having a boiling point of 80 ° C or higher under the conditions of 101.3 kPa is preferably used in terms of availability, workability, and reactivity. These organic solvents may be used alone or in combination of two or more kinds as needed. The amount of the organic solvent to be used is usually 0.1 to 5 times by weight, preferably 0.5 to 3 times by weight, based on 1 part by weight of the phenol compound having an anthracene skeleton represented by the above formula (2).

本發明中所使用之碳酸乙二酯相對於上述式(2)所表示之具有茀 骨架之酚化合物1莫耳,通常使用2~10莫耳,較佳為2~4莫耳。藉由使用2莫耳以上,可獲得充分之反應速度,藉由將使用量設為10莫耳以下,可更經濟地製造上述式(2)所表示之具有茀骨架之醇。 The ethylene carbonate used in the present invention has an antimony expressed in relation to the above formula (2). The skeleton phenolic compound 1 mole is usually used in an amount of 2 to 10 moles, preferably 2 to 4 moles. By using 2 mol or more, a sufficient reaction rate can be obtained, and by using the amount of 10 mol or less, the alcohol having an anthracene skeleton represented by the above formula (2) can be produced more economically.

於使上述式(2)所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應時,視需要於鹼性化合物之存在下進行反應。作為反應步驟中所使用之鹼性化合物,例如可例示碳酸鹽類、碳酸氫鹽類、氫氧化物類、有機鹼類等。更具體而言,作為碳酸鹽類,可例示碳酸鉀、碳酸鈉、碳酸鋰、碳酸銫等,作為碳酸氫鹽類,可例示碳酸氫鉀、碳酸氫鈉、碳酸氫鋰、碳酸氫銫等,作為氫氧化物類,可例示氫氧化鈉、氫氧化鉀、氫氧化鋰等,作為有機鹼類,可例示三乙胺、二甲胺基吡啶、三苯基膦、溴化四甲基銨、氯化四甲基銨等。該等鹼性化合物中,就操作性良好之方面而言,適宜使用碳酸鉀、碳酸鈉、三苯基膦。使用該等鹼性化合物時之使用量相對於上述式(2)所表示之具有茀骨架之酚化合物1莫耳,通常為0.01~1.0莫耳,較佳為0.03~0.2莫耳。 When the phenol compound having an anthracene skeleton represented by the above formula (2) is reacted with ethylene carbonate, the reaction is carried out in the presence of a basic compound as necessary. The basic compound used in the reaction step may, for example, be a carbonate, a hydrogencarbonate, a hydroxide or an organic base. More specifically, examples of the carbonates include potassium carbonate, sodium carbonate, lithium carbonate, and cesium carbonate. Examples of the hydrogencarbonate include potassium hydrogencarbonate, sodium hydrogencarbonate, lithium hydrogencarbonate, and cesium hydrogencarbonate. Examples of the hydroxides include sodium hydroxide, potassium hydroxide, and lithium hydroxide. Examples of the organic bases include triethylamine, dimethylaminopyridine, triphenylphosphine, and tetramethylammonium bromide. Tetramethylammonium chloride and the like. Among these basic compounds, potassium carbonate, sodium carbonate, and triphenylphosphine are preferably used in terms of workability. The amount of the phenol compound having an anthracene skeleton represented by the above formula (2) is usually from 0.01 to 1.0 mol, preferably from 0.03 to 0.2 mol, based on the amount of the phenol compound represented by the above formula (2).

上述式(2)所表示之具有茀骨架之酚化合物與碳酸乙二酯之反應係將上述式(2)所表示之具有茀骨架之酚化合物、碳酸乙二酯、碳數為4以上之鏈狀酮類及視需要之鹼性化合物、可併用之有機溶劑添加至反應容器中,於通常30~150℃、較佳為100~130℃下實施。 The reaction of the phenol compound having an anthracene skeleton represented by the above formula (2) with ethylene carbonate is a phenol compound having an anthracene skeleton represented by the above formula (2), ethylene carbonate, and a chain having a carbon number of 4 or more. The ketones and the optional basic compound and the organic solvent which can be used in combination are added to the reaction container, and are usually carried out at 30 to 150 ° C, preferably 100 to 130 ° C.

包含如此而獲得之上述式(1)所表示之具有茀骨架之醇的反應液可直接進行濃縮、乾燥後用於晶析溶液製備步驟,亦可藉由水洗、吸附處理等後處理、或晶析、管柱純化等常規方法進行純化後用於晶析溶液製備步驟,但藉由實施下述水洗步驟後,用於晶析溶液製備步驟,可提高上述式(1)所表示之具有茀骨架之醇之純度,故而較佳。以下,對水洗步驟進行詳述。 The reaction liquid containing the alcohol having an anthracene skeleton represented by the above formula (1) thus obtained can be directly concentrated, dried, and used for the crystallization solution preparation step, or can be post-treated by water washing, adsorption treatment, or the like. The crystallization solution preparation step is carried out by a conventional method such as precipitation or column purification, but after the water washing step described below, the crystallization solution preparation step can be used to improve the ruthenium skeleton represented by the above formula (1). The purity of the alcohol is preferred. Hereinafter, the washing step will be described in detail.

水洗步驟係於所獲得之反應液中,相對於反應中所使用之上述 式(2)所表示之具有茀骨架之酚化合物1重量倍而添加0.1~10重量倍、較佳為0.5~5重量倍之水,於60~95℃、較佳為70~90℃下進行攪拌,其後藉由靜置、分離水層而實施。藉由使用0.1重量倍以上之水,進一步表現出水洗步驟之效果,藉由將使用量設為10重量倍以下,變得能夠改善容積效率。又,水洗溫度藉由設為60℃以上,靜置時之分液速度變得更快,藉由設為95℃以下,變得能夠抑制水洗時之上述式(1)所表示之具有茀骨架之醇之分解。 The water washing step is carried out in the obtained reaction liquid, relative to the above used in the reaction The phenol compound having an anthracene skeleton represented by the formula (2) is added in an amount of 0.1 to 10 times by weight, preferably 0.5 to 5 times by weight, based on 1 part by weight of the phenolic compound, and is carried out at 60 to 95 ° C, preferably 70 to 90 ° C. Stirring was carried out by standing and separating the aqueous layer. By using 0.1 times by weight or more of water, the effect of the water washing step is further exhibited, and by using the amount of use to 10 times or less, the volumetric efficiency can be improved. In addition, the water-washing temperature is 60° C. or higher, and the liquid separation speed at the time of standing is increased. When the temperature is 95° C. or lower, it is possible to suppress the ruthenium skeleton represented by the above formula (1) at the time of water washing. The decomposition of alcohol.

水洗步驟亦可視需要實施複數次。又,於實施水洗步驟時,亦可藉由與水一併添加鹼或酸而分解副生成物等,或萃取至水層中。 The washing step can also be carried out as many times as needed. Further, when the water washing step is carried out, the by-product or the like may be decomposed by adding a base or an acid together with water, or may be extracted into the aqueous layer.

<晶析溶液製備步驟> <Cleavage solution preparation step>

於藉由上述方法所製造之反應液中包含有芳香族烴類及/或環狀酮類之情形時,需藉由蒸留、濃縮等操作而去除芳香族烴類及/或環狀酮類,使晶析溶液中所含之芳香族烴類及環狀酮類之合計含量成為未達10重量%、較佳為5重量%以下。於晶析溶液中包含10重量%以上之芳香族烴類及/或環狀酮類之情形時,上述式(1)所表示之具有茀骨架之醇包藏有芳香族烴類及/或環狀酮類,無法獲得本發明之結晶。又,即使為5重量%以下,有所獲得之結晶之一部分成為包藏體之情形,因此為了使其確實地不含結晶A,較佳為將晶析溶液中之芳香族烴類及環狀酮類之合計含量設為未達1重量%。 When the reaction liquid produced by the above method contains aromatic hydrocarbons and/or cyclic ketones, it is necessary to remove aromatic hydrocarbons and/or cyclic ketones by distillation, concentration, or the like. The total content of the aromatic hydrocarbons and the cyclic ketones contained in the crystallization solution is less than 10% by weight, preferably 5% by weight or less. When the crystallization solution contains 10% by weight or more of aromatic hydrocarbons and/or cyclic ketones, the alcohol having an anthracene skeleton represented by the above formula (1) contains aromatic hydrocarbons and/or a cyclic group. The ketones do not provide the crystal of the present invention. Further, even if it is 5% by weight or less, a part of the obtained crystal is in the form of an inclusion body. Therefore, in order to surely contain the crystal A, it is preferred to use an aromatic hydrocarbon and a cyclic ketone in the crystallization solution. The total content of the classes was set to be less than 1% by weight.

晶析溶液中所含之碳數為4以上之鏈狀酮類可使用與於上述反應步驟中可使用之鏈狀酮類相同者。該等鏈狀酮類可使用1種,或者視需要將2種以上混合而使用。晶析溶液中所含之碳數為4以上之鏈狀酮類相對於上述式(1)所表示之具有茀骨架之醇1重量倍,於獲得結晶B之情形時為0.5~10重量倍、較佳為1~5重量倍,於獲得結晶C之情形時為0.1~5重量倍、較佳為0.5~4重量倍,於獲得結晶D之情形時為1~15重量倍、較佳為2~10重量倍。藉由設為上述使用量範圍,於晶 析步驟中變得容易分別於所需溫度範圍內使結晶析出,故而較佳。 The chain ketone having 4 or more carbon atoms contained in the crystallization solution can be the same as the chain ketone which can be used in the above reaction step. These chain ketones may be used alone or in combination of two or more kinds as needed. The chain ketone having 4 or more carbon atoms contained in the crystallization solution is 1 to 10 times by weight based on the alcohol having an anthracene skeleton represented by the above formula (1), and 0.5 to 10 times by weight in the case of obtaining the crystal B. It is preferably 1 to 5 times by weight, and is 0.1 to 5 times by weight, preferably 0.5 to 4 times by weight in the case of obtaining crystal C, and 1 to 15 times by weight, preferably 2, in the case of obtaining crystal D. ~10 times the weight. By setting the above usage range, Yu Jing In the precipitation step, it is easy to precipitate crystals in a desired temperature range, which is preferable.

於晶析溶液中,除了碳數為4以上之鏈狀酮類以外,就提高所獲得之結晶B、C或D之獲得量之觀點而言,較佳為併用脂肪族烴類(例如己烷、庚烷、辛烷等)。併用脂肪族烴類之情形時之使用量通常相對於上述式(1)所表示之具有茀骨架之醇1重量倍為0.3~5重量倍、較佳為0.5~3重量倍。又,亦可併用對於上述式(1)所表示之具有茀骨架之醇為非活性之脂肪族烴類以外之溶劑(其中芳香族烴類及環狀酮類除外),但為了更確實地獲得本發明之結晶,較佳為不併用脂肪族烴類以外之其他溶劑。 In the crystallization solution, in addition to the chain ketone having a carbon number of 4 or more, in terms of increasing the amount of the obtained crystal B, C or D, it is preferred to use an aliphatic hydrocarbon (for example, hexane). , heptane, octane, etc.). In the case of using an aliphatic hydrocarbon in combination, the amount used is usually 0.3 to 5 times by weight, preferably 0.5 to 3 times by weight, based on 1 part by weight of the alcohol having an anthracene skeleton represented by the above formula (1). Further, a solvent other than the aliphatic hydrocarbons in which the alcohol having an anthracene skeleton represented by the above formula (1) is inactive (excluding aromatic hydrocarbons and cyclic ketones) may be used in combination, but in order to obtain more surely The crystal of the present invention is preferably a solvent other than an aliphatic hydrocarbon.

<晶析步驟> <Cleavage step>

如上所述而獲得之晶析溶液於晶析溶液中包含有結晶之情形時,使該結晶完全溶解後進行冷卻,於獲得結晶B之情形時,於75~85℃下使結晶析出,於獲得結晶C之情形時,於90~100℃下使結晶析出,於獲得結晶D之情形時,於70℃以下使結晶析出。以下,詳述於該溫度範圍內使結晶析出之方法。 When the crystallization solution obtained as described above contains crystals in the crystallization solution, the crystals are completely dissolved and then cooled, and when the crystal B is obtained, the crystals are precipitated at 75 to 85 ° C to obtain In the case of the crystal C, the crystal is precipitated at 90 to 100 ° C, and when the crystal D is obtained, the crystal is precipitated at 70 ° C or lower. Hereinafter, a method of depositing crystals in this temperature range will be described in detail.

於75~85℃下使結晶析出之情形時,將晶析溶液加熱至75℃以上、晶析溶液之沸點以下,較佳為加熱至100~110℃後,以0.3℃~1.0℃/分鐘、較佳為0.5~0.9℃/分鐘之速度進行冷卻,其後於75~85℃下使結晶析出。作為於75~85℃下使結晶析出之方法,可列舉於相同溫度下繼續攪拌直至結晶析出之方法、於上述溫度範圍內接種晶種之方法等。於添加晶種之情形時,可為結晶B、結晶C、結晶D或公知之結晶A,但為了更確實地獲得結晶B,較佳為將結晶B用作晶種。又,於結晶析出後於相同溫度下保持一定時間並使結晶成長之方法可更確實地獲得本發明之結晶,故而較佳。 When the crystal is precipitated at 75 to 85 ° C, the crystallization solution is heated to 75 ° C or higher and below the boiling point of the crystallization solution, preferably after heating to 100 to 110 ° C, at 0.3 ° C to 1.0 ° C / min, It is preferably cooled at a rate of 0.5 to 0.9 ° C / minute, and then crystallized at 75 to 85 ° C. Examples of the method for precipitating crystals at 75 to 85 ° C include a method of continuing stirring at the same temperature until crystallization is precipitated, a method of inoculating seed crystals in the above temperature range, and the like. In the case of adding a seed crystal, it may be crystal B, crystal C, crystal D or known crystal A, but in order to obtain crystal B more reliably, it is preferred to use crystal B as a seed crystal. Further, it is preferred that the crystal of the present invention can be obtained more reliably by maintaining the crystal at a constant temperature for a certain period of time after crystal precipitation.

於90~100℃下使結晶析出之情形時,將晶析溶液加熱至90℃以上、晶析溶液之沸點以下,較佳為加熱至100~110℃後,以0.05℃~ 0.5℃/分鐘,較佳為以0.08~0.3℃/分鐘之速度進行冷卻,其後於90~100℃下使結晶析出。作為於90~100℃下使結晶析出之方法,可列舉於相同溫度下繼續攪拌直至結晶析出之方法、於上述溫度範圍接種晶種之方法等。於添加晶種之情形時,可為結晶B、結晶C、結晶D或公知之結晶A,但為了更確實地獲得結晶C,較佳為將結晶C用作晶種。又,於結晶析出後於相同溫度下保持一定時間並使結晶成長之方法可更確實地獲得本發明之結晶,故而更佳。 When the crystal is precipitated at 90 to 100 ° C, the crystallization solution is heated to 90 ° C or higher, below the boiling point of the crystallization solution, preferably after heating to 100 to 110 ° C, and 0.05 ° C. The temperature is 0.5 ° C / min, preferably at a rate of 0.08 - 0.3 ° C / min, and then the crystal is precipitated at 90 - 100 ° C. Examples of the method for precipitating crystals at 90 to 100 ° C include a method of continuing stirring at the same temperature until precipitation of crystals, a method of inoculating seed crystals in the above temperature range, and the like. In the case of adding a seed crystal, it may be crystal B, crystal C, crystal D or a known crystal A, but in order to obtain crystal C more reliably, it is preferred to use crystal C as a seed crystal. Further, it is more preferable to obtain the crystal of the present invention more reliably by maintaining the crystal at a same temperature for a certain period of time after crystal precipitation.

於70℃以下使結晶析出之情形時,將晶析溶液加熱至70℃以上、晶析溶液之沸點以下,較佳為加熱至100~110℃後,以0.5℃~2.0℃/分鐘,較佳為以1.0~1.5℃/分鐘之速度進行冷卻,其後於70℃以下使結晶析出。作為於70℃以下使結晶析出之方法,可列舉於相同溫度下繼續攪拌直至結晶析出之方法、於上述溫度範圍內接種晶種之方法等。於添加晶種之情形時,可為結晶B、結晶C、結晶D或公知之結晶A,但為了更確實地獲得結晶D,較佳為將結晶D用作晶種。又,於結晶析出後於相同溫度下保持一定時間並使結晶成長之方法可更確實地獲得本發明之結晶,故而較佳。 When the crystal is precipitated at 70 ° C or lower, the crystallization solution is heated to 70 ° C or higher and the boiling point of the crystallization solution or lower, preferably after heating to 100 to 110 ° C, preferably 0.5 ° C to 2.0 ° C / min. The cooling was carried out at a rate of 1.0 to 1.5 ° C /min, and thereafter, the crystal was precipitated at 70 ° C or lower. Examples of the method for precipitating crystals at 70 ° C or lower include a method of continuing stirring at the same temperature until crystal precipitation, a method of inoculating seed crystals in the above temperature range, and the like. In the case of adding a seed crystal, it may be crystal B, crystal C, crystal D or a known crystal A, but in order to obtain crystal D more reliably, it is preferred to use crystal D as a seed crystal. Further, it is preferred that the crystal of the present invention can be obtained more reliably by maintaining the crystal at a constant temperature for a certain period of time after crystal precipitation.

亦可於如上所述之特定之溫度範圍內使結晶析出後,將於與結晶析出溫度相同之溫度下析出之結晶分離,但為了更高產率地獲得結晶,較佳為冷卻至30℃以下後,將析出之結晶分離。分離後之結晶亦可視需要進行乾燥,去除結晶上所附著之碳數為4以上之鏈狀酮類等。再者,由於本發明之結晶並非包藏體,故而藉由在反應、晶析步驟中所使用之碳數為4以上之鏈狀酮類等之沸點以上之溫度下進行乾燥,可去除碳數為4以上之鏈狀酮類等,因此可保持結晶狀態並去除碳數為4以上之鏈狀酮類等。再者,於公知之結晶A之情形時,由於所包藏之芳香族烴類被釋出之溫度與結晶之熔點大致相同,故而若欲藉由加熱而自結晶A去除芳香族烴類,則結晶會暫時熔融,因此於芳 香族烴類釋出後,若進行冷卻,則不再為結晶,而成為非晶質體。 Further, after the crystals are precipitated in the specific temperature range as described above, the crystals precipitated at the same temperature as the crystallization temperature may be separated, but in order to obtain crystals at a higher yield, it is preferred to cool to 30 ° C or lower. The precipitated crystals are separated. The separated crystals may be dried as needed to remove chain ketones having a carbon number of 4 or more attached to the crystal. In addition, since the crystal of the present invention is not an inclusion body, the carbon number can be removed by drying at a temperature equal to or higher than the boiling point of a chain ketone having a carbon number of 4 or more used in the reaction or crystallization step. Since the chain ketones and the like of 4 or more are in a crystalline state, chain ketones having a carbon number of 4 or more can be removed. Further, in the case of the known crystal A, since the temperature at which the encapsulated aromatic hydrocarbon is released is substantially the same as the melting point of the crystal, if the aromatic hydrocarbon is removed from the crystal A by heating, the crystal is crystallized. Will melt temporarily, so Yu Fang When the aromatic hydrocarbon is released, if it is cooled, it is no longer crystallized and becomes an amorphous body.

如此而獲得之本發明之結晶亦可視需要反覆進行吸附、水蒸氣蒸餾、再結晶等通常之純化操作,但即使不實施此種操作,亦為充分高之純度,又,由於並非包藏體,故而當然適宜用作聚碳酸酯、聚酯、聚丙烯酸酯、聚胺基甲酸酯、環氧樹脂等樹脂材料,此外亦可適宜地用於客體分子成為問題之領域、例如醫藥農藥用之原料(中間體)。 The crystal of the present invention thus obtained may be subjected to a usual purification operation such as adsorption, steam distillation, recrystallization, etc., if necessary, but it is sufficiently high in purity without performing such an operation, and since it is not an inclusion body, Of course, it is suitably used as a resin material such as polycarbonate, polyester, polyacrylate, polyurethane, epoxy resin, etc., and can also be suitably used in the field where the guest molecule becomes a problem, for example, a raw material for pharmaceutical pesticides ( Intermediate).

[實施例] [Examples]

以下,列舉實施例及試驗例對本發明進行具體說明,但本發明並不限定於此。再者,例中之各種測定係藉由下述方法而實施。再者,以下之實施例、比較例、參考例中所記載之各成分之生成率(殘留率)及純度係於下述條件下所測得之HPLC之面積百分率。 Hereinafter, the present invention will be specifically described by way of examples and test examples, but the present invention is not limited thereto. Further, various measurements in the examples were carried out by the following methods. In addition, the production rate (residual ratio) and purity of each component described in the following examples, comparative examples, and reference examples are the area percentages of HPLC measured under the following conditions.

(1)HPLC純度 (1) HPLC purity

裝置:島津製作所製造之LC-2010A、管柱:SMMIPAX ODS A-211(5μm、4.6mm ×250mm)、流動相:純水/乙腈(乙腈30%→100%)、流量:1.0ml/min、管柱溫度:40℃、檢測波長:UV 254nm。 Device: LC-2010A manufactured by Shimadzu Corporation, column: SMMIPAX ODS A-211 (5μm, 4.6mm ×250 mm), mobile phase: pure water/acetonitrile (acetonitrile 30%→100%), flow rate: 1.0 ml/min, column temperature: 40 ° C, detection wavelength: UV 254 nm.

(2)殘留溶劑量、包藏溶劑量之分析 (2) Analysis of the amount of residual solvent and the amount of occluded solvent

對於溶劑之殘留量、或上述式(1)所表示之具有茀骨架之醇中所包藏之客體分子(芳香族烴類等)之含量,藉由基於下述條件之氣相層析法進行定量。 The content of the residual amount of the solvent or the guest molecule (aromatic hydrocarbon or the like) contained in the alcohol having an anthracene skeleton represented by the above formula (1) is quantified by gas chromatography based on the following conditions. .

裝置:島津製作所製造之GC-2014、管柱:DB-1(0.25μm、0.25mmID×30m)、升溫:40℃(保持5分鐘)→20℃/min→250℃(保持10分鐘)、Inj溫度:250℃、Det溫度:300℃、分流比1:10、載體:氮氣54.4kPa(固定)、 樣品製備方法:稱取經充分乾燥之上述式(1)所表示之具有茀骨架之醇之結晶100mg置於10ml量瓶中,利用全移液管向其中加入預先製備之1,2-二甲氧基乙烷之乙腈溶液(將1,2-二甲氧基乙烷400mg溶解至乙腈200ml中而成者)5ml,將利用乙腈進行定容並溶解所得者作為試樣溶液。 Device: GC-2014 manufactured by Shimadzu Corporation, column: DB-1 (0.25 μm, 0.25 mm ID × 30 m), temperature rise: 40 ° C (for 5 minutes) → 20 ° C / min → 250 ° C (for 10 minutes), Inj Temperature: 250 ° C, Det temperature: 300 ° C, split ratio 1:10, carrier: nitrogen 54.4 kPa (fixed), Sample preparation method: 100 mg of the crystal of the alcohol having an anthracene skeleton represented by the above formula (1), which was sufficiently dried, was placed in a 10 ml volumetric flask, and a previously prepared 1,2-dimethoxygen was added thereto by using a full pipette. 5 ml of an ethyl acetonitrile solution (formed by dissolving 400 mg of 1,2-dimethoxyethane in 200 ml of acetonitrile), and the solution was adjusted to a volume of acetonitrile and dissolved to obtain a sample solution.

另一方面,稱取欲測定殘留量(包藏量)之化合物10mg置於10ml量瓶中,加入與上述同量之1,2-二甲氧基乙烷之乙腈溶液,將利用乙腈進行定容並溶解所得者作為標準溶液。 On the other hand, 10 mg of the compound to be measured for the residual amount (occlusion amount) is weighed into a 10 ml volumetric flask, and the same amount of the above-mentioned 1,2-dimethoxyethane in acetonitrile is added to make a constant volume using acetonitrile. The resulting product was dissolved as a standard solution.

於上述之條件下分析試樣溶液及標準溶液,利用資料處理裝置求出所獲得之各成分之波峰面積,算出各成分之含量(重量%)(內部標準法)。 The sample solution and the standard solution were analyzed under the above conditions, and the peak area of each component obtained was determined by a data processing apparatus, and the content (% by weight) of each component was calculated (internal standard method).

(3)用以確認為包藏體之分析 (3) Analysis to confirm the inclusion

精確地稱取上述式(1)所表示之具有茀骨架之醇之結晶5mg置於鋁鍋中,使用Rigaku公司(股份)製造之示差熱天秤TG-DTA8121,於下述操作條件下進行測定。 5 mg of the crystal of the alcohol having an anthracene skeleton represented by the above formula (1) was accurately weighed and placed in an aluminum pan, and the measurement was carried out under the following operating conditions using a differential thermal scale TG-DTA8121 manufactured by Rigaku Co., Ltd.

(操作條件) (Operating conditions)

升溫速度:10℃/min、測定範圍:30-250℃、環境:開放、氮氣250ml/min。 Heating rate: 10 ° C / min, measuring range: 30-250 ° C, environment: open, nitrogen 250 ml / min.

(4)示差掃描熱量測定(DSC) (4) Differential Scanning Calorimetry (DSC)

精確地稱取上述式(1)所表示之具有茀骨架之醇之結晶5mg置於鋁鍋中,使用示差掃描熱量計(SII NanoTechnology股份有限公司:DSC7020),於下述操作條件下,以氧化鋁為對照進行測定。 5 mg of the crystal of the alcohol having an anthracene skeleton represented by the above formula (1) was accurately weighed and placed in an aluminum pan, and oxidized using a differential scanning calorimeter (SII NanoTechnology Co., Ltd.: DSC7020) under the following operating conditions. Aluminum was measured for the control.

(操作條件) (Operating conditions)

升溫速度:10℃/min、測定範圍:30-250℃、 環境:開放、氮氣40ml/min。 Heating rate: 10 ° C / min, measuring range: 30-250 ° C, Environment: Open, nitrogen 40 ml/min.

(5)粉末X線繞射 (5) Powder X-ray diffraction

將上述式(1)所表示之具有茀骨架之醇之結晶150mg填充至玻璃試驗板之試樣填充部,使用粉末X線繞射裝置(Spectris公司製造:X'PertPRO),於下述之條件下進行測定。 150 mg of the crystal of the alcohol having an anthracene skeleton represented by the above formula (1) was filled in a sample filling portion of a glass test plate, and a powder X-ray diffraction apparatus (manufactured by Spectris: X'PertPRO) was used under the following conditions. The measurement was carried out.

X線源:CuKα、輸出:1.8kW(45kV-40mA)、測定範圍:2θ=5°~70°、掃描速度:2θ=2°/min、狹縫:DS=1°、遮罩=15mm、RS=可変(0.1mm~)。 X-ray source: CuKα, output: 1.8kW (45kV-40mA), measurement range: 2θ=5°~70°, scanning speed: 2θ=2°/min, slit: DS=1°, mask=15mm, RS = 変 (0.1mm~).

(6)YI值 (6) YI value

使上述式(1)所表示之具有茀骨架之醇之結晶12g溶解至純度99重量%以上之N,N-二甲基甲醯胺30ml中,測定於以下之條件下所獲得之N,N-二甲基甲醯胺溶液之YI值(黃度)。 12 g of the alcohol having an anthracene skeleton represented by the above formula (1) was dissolved in 30 ml of N,N-dimethylformamide having a purity of 99% by weight or more, and N, N obtained under the following conditions was measured. - YI value (yellowness) of dimethylformamide solution.

裝置:色差計(日本電色工業公司製造,SE6000)、使用元件:光程長度為33mm之石英元件。 Device: Color difference meter (manufactured by Nippon Denshoku Industries Co., Ltd., SE6000), using components: quartz element with an optical path length of 33 mm.

再者,為了使測定中所使用之N,N-二甲基甲醯胺本身之著色不會對測定值產生影響,而預先測定N,N-二甲基甲醯胺之色相並加以修正(空白測定)。於實施該空白測定之基礎上,將測定樣品所獲得之值作為本發明中之YI值。 Further, in order to make the color of the N,N-dimethylformamide itself used for the measurement does not affect the measured value, the hue of N,N-dimethylformamide is measured in advance and corrected ( Blank determination). Based on the implementation of the blank measurement, the value obtained by measuring the sample is taken as the YI value in the present invention.

(7)鬆密度 (7) bulk density

將實施例及比較例中所獲得之結晶放入10ml之量筒中,直至達到5ml,由進入量筒中之結晶之重量而算出鬆密度。 The crystals obtained in the examples and the comparative examples were placed in a 10 ml measuring cylinder until 5 ml was reached, and the bulk density was calculated from the weight of the crystals entering the measuring cylinder.

<實施例1> <Example 1>

向具備攪拌器、加熱冷卻器、及溫度計之玻璃製反應器中,裝入上述式(2)所表示之具有茀骨架之酚化合物(9,9'-雙(4-羥基-3-苯基苯 基)茀)120g(0.239mol)、碳酸鉀2.8g(0.020mol)、碳酸乙二酯48g(0.545mol)、甲基異丁基酮(以下,亦有稱為MIBK之情形)180g,升溫至120℃,於相同溫度下攪拌6小時後,利用HPLC確認原料消失。 Into a glass reactor equipped with a stirrer, a heating cooler, and a thermometer, a phenol compound having an anthracene skeleton represented by the above formula (2) (9,9'-bis(4-hydroxy-3-phenyl group) was charged. benzene 120 g (0.239 mol), potassium carbonate 2.8 g (0.020 mol), ethylene carbonate 48 g (0.545 mol), methyl isobutyl ketone (hereinafter also referred to as MIBK) 180 g, and the temperature was raised to After stirring at 120 ° C for 6 hours at the same temperature, the disappearance of the starting material was confirmed by HPLC.

將所獲得之反應液冷卻至80℃後,加入MIBK 180g、水180g,於80~85℃下攪拌1小時,靜置後,將水層分離。重複3次相同操作後,添加MIBK 130g、庚烷210g,而獲得晶析溶液。 After cooling the obtained reaction liquid to 80 ° C, 180 g of MIBK and 180 g of water were added, and the mixture was stirred at 80 to 85 ° C for 1 hour, and after standing, the aqueous layer was separated. After the same operation was repeated 3 times, MIBK 130 g and heptane 210 g were added to obtain a crystallization solution.

將所獲得之晶析溶液升溫至100℃,攪拌30分鐘而使結晶完全溶解後,藉由使該晶析溶液以0.8℃/分鐘之速度進行冷卻而於80℃下使結晶析出,於相同溫度下攪拌2小時。攪拌後,進而冷卻至25℃,而獲得結晶。 The obtained crystallization solution was heated to 100 ° C, stirred for 30 minutes to completely dissolve the crystal, and then the crystallization solution was cooled at a rate of 0.8 ° C / minute to precipitate crystals at 80 ° C at the same temperature. Stir under 2 hours. After stirring, it was further cooled to 25 ° C to obtain crystals.

將所獲得之結晶於內壓0.4kPa之減壓下、內溫85~90℃下乾燥9小時,結果因MIBK及庚烷之合計含量成為0.2重量%,故而結束乾燥。 The obtained crystals were dried under an internal pressure of 0.4 kPa under reduced pressure at an internal temperature of 85 to 90 ° C for 9 hours. As a result, the total content of MIBK and heptane was 0.2% by weight, and the drying was completed.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:125g(產率:82%)、HPLC純度:98.6%、101.3kPa下之沸點為150℃以下之有機溶劑之含量(包括MIBK及庚烷之含量):0.24重量%、YI值:5.2、DSC熔解吸熱最大溫度:175℃、鬆密度:0.5g/cm3Weight of crystal obtained: 125 g (yield: 82%), HPLC purity: 98.6%, content of organic solvent having a boiling point of 150 ° C or less at 101.3 kPa (including the content of MIBK and heptane): 0.24% by weight, YI value: 5.2, DSC melting endothermic maximum temperature: 175 ° C, bulk density: 0.5 g / cm 3 .

將DSC分析圖示於圖1,將粉末X線之圖譜示於圖4,將粉末X線之主要波峰(具有超過5%之相對強度者)列舉至表1。如表1所示,本實施例中所獲得之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=7.7±0.2°、17.2±0.2°、18.3±0.2°、19.6±0.2°、20.8±0.2°及21.4±0.2°處 顯示出特徵性繞射波峰(以下,亦有將具有與本圖譜相同之X線波峰者稱為「圖譜B」之情形)。 The DSC analysis is shown in Figure 1, the powder X-ray pattern is shown in Figure 4, and the main peaks of the powder X-ray (with a relative strength of more than 5%) are listed in Table 1. As shown in Table 1, the alcohol having an anthracene skeleton represented by the above formula (1) obtained in the present example has a diffraction angle of 2θ=7.7±0.2°, 17.2±0.2°, 18.3±0.2°, and 19.6±0.2. °, 20.8 ± 0.2 ° and 21.4 ± 0.2 ° A characteristic diffraction peak is shown (hereinafter, a case where the X-ray peak having the same spectrum as the map is referred to as "Map B") is also shown.

<實施例2> <Example 2>

向具備攪拌器、加熱冷卻器、及溫度計之玻璃製反應器中裝入上述式(2)所表示之具有茀骨架之酚化合物(9,9'-雙(4-羥基-3-苯基苯基)茀)138g(0.275mol)、碳酸鉀3.1g(0.022mol)、碳酸乙二酯50.8g(0.577mol)、MIBK 138g,升溫至120℃,於相同溫度下攪拌9小時後,利用HPLC而確認原料消失。 A phenol compound having an anthracene skeleton represented by the above formula (2) (9,9'-bis(4-hydroxy-3-phenylbenzene) is charged into a glass reactor equipped with a stirrer, a heating cooler, and a thermometer. 138g (0.275mol), potassium carbonate 3.1g (0.022mol), ethylene carbonate 50.8g (0.577mol), MIBK 138g, heated to 120 ° C, stirred at the same temperature for 9 hours, using HPLC Confirm that the raw materials disappear.

將所獲得之反應液冷卻至80℃後,加入MIBK 276g、水207g,於70~75℃下攪拌2小時,靜置後,將水層分離。重複3次相同操作後,添加MIBK 55g、庚烷198g,而獲得晶析溶液。 After cooling the obtained reaction liquid to 80 ° C, 276 g of MIBK and 207 g of water were added, and the mixture was stirred at 70 to 75 ° C for 2 hours, and after standing, the aqueous layer was separated. After repeating the same operation three times, MIBK 55 g and heptane 198 g were added to obtain a crystallization solution.

將所獲得之晶析溶液升溫至105℃,攪拌30分鐘而使結晶完全溶解後,藉由將該晶析溶液以0.1℃/分鐘之速度進行冷卻而於95℃下使結晶析出,於相同溫度下攪拌2小時。其後,冷卻至25℃,進行過濾,而獲得結晶。 The obtained crystallization solution was heated to 105 ° C, stirred for 30 minutes to completely dissolve the crystal, and then the crystallization solution was cooled at a rate of 0.1 ° C / minute to precipitate crystals at 95 ° C at the same temperature. Stir under 2 hours. Thereafter, it was cooled to 25 ° C and filtered to obtain crystals.

將所獲得之結晶於內壓1.3kPa之減壓下、於內溫80~90℃下乾燥3小時,結果因MIBK之含量成為0.06重量%,故而結束乾燥。 The obtained crystals were dried at an internal temperature of 80 to 90 ° C for 3 hours under reduced pressure of an internal pressure of 1.3 kPa. As a result, the content of MIBK was 0.06% by weight, and the drying was completed.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:127g(產率:78%)、HPLC純度:98.7%、101.3kPa下之沸點為150℃以下之有機溶劑之含量(包含MIBK及庚烷之含量):0.07重量%、YI值:7.0、DSC熔解吸熱最大溫度:195℃、鬆密度:0.6g/cm3Weight of crystal obtained: 127 g (yield: 78%), HPLC purity: 98.7%, content of organic solvent having a boiling point of 150 ° C or less at 101.3 kPa (including the content of MIBK and heptane): 0.07 wt%, YI value: 7.0, DSC melting endothermic maximum temperature: 195 ° C, bulk density: 0.6 g / cm 3 .

將DSC分析圖示於圖2,將粉末X線之圖譜示於圖5,將粉末X線之主要波峰(具有超過5%之相對強度者)列舉至表2。如表2所示,本實施例所獲得之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=14.9±0.2°、17.8±0.2°、18.9±0.2°、19.7±0.2°、20.0±0.2°及21.0±0.2°處顯示出特徵性繞射波峰(以下,亦有將具有與本圖譜相同之X線波峰者稱為「圖譜C」之情形)。 The DSC analysis is shown in Figure 2, the powder X-ray pattern is shown in Figure 5, and the main peaks of the powder X-ray (with a relative strength of more than 5%) are listed in Table 2. As shown in Table 2, the alcohol having an anthracene skeleton represented by the above formula (1) obtained in the present example has a diffraction angle of 2θ=14.9±0.2°, 17.8±0.2°, 18.9±0.2°, and 19.7±0.2°. Characteristic diffraction peaks are exhibited at 20.0±0.2° and 21.0±0.2° (hereinafter, the case where the X-ray peak having the same spectrum as the map is also referred to as “Map C”).

<實施例3> <Example 3>

向具備攪拌器、加熱冷卻器、及溫度計之玻璃製反應器中裝入上述式(2)所表示之具有茀骨架之酚化合物(9,9'-雙(4-羥基-3-苯基苯基)茀)150g(0.298mol)、碳酸鉀3.4g(0.025mol)、碳酸乙二酯65.7g(0.747mol)、甲基異戊基酮(以下,亦有稱為MIAK之情形)150g,升溫至120℃,於相同溫度下攪拌7小時後,利用HPLC而確認原料消失。 A phenol compound having an anthracene skeleton represented by the above formula (2) (9,9'-bis(4-hydroxy-3-phenylbenzene) is charged into a glass reactor equipped with a stirrer, a heating cooler, and a thermometer. 150 g (0.298 mol), potassium carbonate 3.4 g (0.025 mol), ethylene carbonate 65.7 g (0.747 mol), methyl isoamyl ketone (hereinafter, also referred to as MIAK) 150 g, heating After stirring at the same temperature for 7 hours at 120 ° C, the disappearance of the starting material was confirmed by HPLC.

將所獲得之反應液冷卻至90℃後,加入水150g,於85~90℃下攪拌30分鐘,靜置後,將水層分離。重複3次相同操作後,添加MIAK250g,而獲得晶析溶液。 After cooling the obtained reaction liquid to 90 ° C, 150 g of water was added thereto, and the mixture was stirred at 85 to 90 ° C for 30 minutes, and after standing, the aqueous layer was separated. After repeating the same operation three times, 250 g of MIAK was added to obtain a crystallization solution.

將所獲得之晶析溶液升溫至110℃,攪拌30分鐘而使結晶完全溶解後,將該晶析溶液以0.3℃/分鐘之速度冷卻至98℃,於相同溫度下,將實施例2中所獲得之結晶20mg作為晶種進行接種,攪拌10分鐘,結果因結晶開始析出,故而於相同溫度下攪拌1小時。攪拌後,進而冷卻至22℃後,進行過濾,而獲得結晶。 The obtained crystallization solution was heated to 110 ° C, stirred for 30 minutes to completely dissolve the crystal, and then the crystallization solution was cooled to 98 ° C at a rate of 0.3 ° C / min. At the same temperature, in Example 2 20 mg of the obtained crystal was inoculated as a seed crystal, and the mixture was stirred for 10 minutes. As a result, precipitation of crystals began, and the mixture was stirred at the same temperature for 1 hour. After stirring, the mixture was further cooled to 22 ° C, and then filtered to obtain crystals.

將所獲得之結晶於內壓1.3kPa之減壓下、內溫80~90℃,攪拌3小時,結果因MIAK之含量成為0.07重量%,故而結束乾燥。 The obtained crystal was stirred at an internal temperature of 80 to 90 ° C under an internal pressure of 1.3 kPa, and stirred for 3 hours. As a result, the content of MIAK was 0.07% by weight, and the drying was completed.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:112g(產率:64%)、 HPLC純度:98.1%、101.3kPa下之沸點為150℃以下之有機溶劑之含量(包含MIAK):0.08重量%、YI值:1.7、DSC熔解吸熱最大溫度:195℃、鬆密度:0.8g/cm3、X線繞射圖譜:圖譜C。 Weight of crystal obtained: 112 g (yield: 64%), HPLC purity: 98.1%, content of organic solvent having a boiling point of 150 ° C or less at 101.3 kPa (including MIAK): 0.08 wt%, YI value: 1.7, DSC melting endothermic maximum temperature: 195 ° C, bulk density: 0.8 g / cm 3 , X-ray diffraction pattern: map C.

<實施例4> <Example 4>

利用與實施例1相同之規模、同樣之方法進行反應步驟、水洗步驟後,向所獲得之水洗步驟後之反應液中添加MIBK 240g、庚烷240g,而獲得晶析溶液。 After the reaction step and the water washing step were carried out in the same manner as in Example 1, the MIBK 240 g and the heptane (240 g) were added to the reaction liquid after the obtained water washing step to obtain a crystallization solution.

將所獲得之晶析溶液升溫至100℃,攪拌30分鐘而使結晶完全溶解後,藉由將該晶析溶液以1.5℃/分鐘之速度進行冷卻而於69℃下使結晶析出,於相同溫度下攪拌2小時。攪拌後,進而冷卻至20℃後,進行過濾,而獲得結晶。 The obtained crystallization solution was heated to 100 ° C, stirred for 30 minutes to completely dissolve the crystal, and then the crystallization solution was cooled at a rate of 1.5 ° C / minute to precipitate crystals at 69 ° C at the same temperature. Stir under 2 hours. After stirring, the mixture was further cooled to 20 ° C, and then filtered to obtain crystals.

將所獲得之結晶於內壓1.3kPa之減壓下、內溫80~85℃下乾燥3小時,結果因MIBK及庚烷之合計含量成為0.8重量%,故而結束乾燥。 The obtained crystals were dried under reduced pressure of an internal pressure of 1.3 kPa at an internal temperature of 80 to 85 ° C for 3 hours. As a result, the total content of MIBK and heptane was 0.8% by weight, and the drying was completed.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:107g(產率:76%)、HPLC純度:98.3%、101.3kPa下之沸點為150℃以下之有機溶劑之含量(包含MIBK及庚烷之含量):0.8重量%、YI值:4.5、DSC熔解吸熱最大溫度:169℃、 鬆密度:1.5g/cm3Weight of crystal obtained: 107 g (yield: 76%), HPLC purity: 98.3%, content of organic solvent having a boiling point of 150 ° C or less at 101.3 kPa (including the content of MIBK and heptane): 0.8% by weight, YI value: 4.5, DSC melting endothermic maximum temperature: 169 ° C, bulk density: 1.5 g / cm 3 .

將DSC分析圖示於圖9,將粉末X線之圖譜示於圖10,將粉末X線之主要波峰(具有超過5%之相對強度者)列舉至表6。如表6所示,本實施例所獲得之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=9.8±0.2°、14.9±0.2°、17.6±0.2°、18.8±0.2°、19.4±0.2°、20.0±0.2及20.6±0.2°處顯示出特徵性繞射波峰(以下,亦有將具有與本圖譜相同之X線波峰者稱為「圖譜D」之情形)。 The DSC analysis is shown in Figure 9, the powder X-ray pattern is shown in Figure 10, and the main peaks of the powder X-ray (with a relative strength of more than 5%) are listed in Table 6. As shown in Table 6, the alcohol having an anthracene skeleton represented by the above formula (1) obtained in the present example has a diffraction angle of 2θ=9.8±0.2°, 14.9±0.2°, 17.6±0.2°, and 18.8±0.2°. Characteristic diffraction peaks are exhibited at 19.4±0.2°, 20.0±0.2, and 20.6±0.2° (hereinafter, the case where the X-ray peak having the same spectrum as the spectrum is also referred to as “Map D”).

<比較例1> <Comparative Example 1>

向具備攪拌器、加熱冷卻器、及溫度計之玻璃製反應器中裝入上述式(2)所表示之具有茀骨架之酚化合物(9,9'-雙(4-羥基-3-苯基苯基)茀)40.0g(0.080mol)、碳酸乙二酯16.1g(0.183mol)、碳酸鉀0.8g(0.006mol)及甲苯40.0g,於110℃下攪拌11小時,利用HPLC而確認原料波峰為1%以下。 A phenol compound having an anthracene skeleton represented by the above formula (2) (9,9'-bis(4-hydroxy-3-phenylbenzene) is charged into a glass reactor equipped with a stirrer, a heating cooler, and a thermometer. 40.0 g (0.080 mol), ethylene carbonate (16.1 g (0.183 mol), potassium carbonate 0.8 g (0.006 mol), and toluene 40.0 g, and the mixture was stirred at 110 ° C for 11 hours, and the peak of the raw material was confirmed by HPLC. 1% or less.

將所獲得之反應液冷卻至85℃後,加入水68g,於80~85℃下攪拌30分鐘,靜置後,將水層分離。重複3次相同操作後,使用迪安-斯塔克裝置將所獲得之有機溶劑層於回流狀態下進行脫水,而獲得溶解有上述式(1)所表示之具有茀骨架之醇的晶析溶液。 After cooling the obtained reaction liquid to 85 ° C, 68 g of water was added, and the mixture was stirred at 80 to 85 ° C for 30 minutes, and after standing, the aqueous layer was separated. After the same operation was repeated 3 times, the obtained organic solvent layer was dehydrated under reflux using a Dean-Stark apparatus to obtain a crystallization solution in which the alcohol having an anthracene skeleton represented by the above formula (1) was dissolved. .

將所獲得之晶析溶液以0.3℃/分鐘之速度冷卻後,於65℃下析出結晶,於相同溫度下攪拌2小時。攪拌後,進而冷卻至26℃後,進行過濾,而獲得結晶。 After the obtained crystallization solution was cooled at a rate of 0.3 ° C /min, crystals were precipitated at 65 ° C and stirred at the same temperature for 2 hours. After stirring, the mixture was further cooled to 26 ° C, and then filtered to obtain crystals.

將所獲得之結晶於內壓1.1kPa之減壓下、內溫68℃~73℃下乾燥3小時,但由於含有甲苯4重量%,故而將內溫升溫至110℃,於相同溫度下進而乾燥3小時,但甲苯之含量仍為4重量%。 The obtained crystal was dried under reduced pressure of internal pressure of 1.1 kPa at an internal temperature of 68 ° C to 73 ° C for 3 hours. However, since the content of toluene was 4% by weight, the internal temperature was raised to 110 ° C and dried at the same temperature. 3 hours, but the toluene content was still 4% by weight.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:39.3g、 HPLC純度:97.5%、甲苯含量:4.1重量%、DSC熔解吸熱最大溫度:151℃、鬆密度:0.3g/cm3The weight of the obtained crystal: 39.3 g, HPLC purity: 97.5%, toluene content: 4.1% by weight, DSC melting endothermic maximum temperature: 151 ° C, bulk density: 0.3 g/cm 3 .

將DSC分析圖示於圖3,將粉末X線之圖譜示於圖6,將粉末X線之主要波峰(具有超過5%之相對強度者)列舉至表3,將TG-DTA之分析圖示於圖7。如表3所示,本比較例中所獲得之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=7.6±0.2°、15.6±0.2°、16.4±0.2°、18.7±0.2°、19.0±0.2°、20.5±0.2°及23.6±0.2°處顯示出特徵性繞射波峰。 The DSC analysis is shown in Figure 3, the powder X-ray pattern is shown in Figure 6, and the main peaks of the powder X-ray (with a relative intensity of more than 5%) are listed in Table 3, and the TG-DTA analysis icon is shown. In Figure 7. As shown in Table 3, the alcohol having an anthracene skeleton represented by the above formula (1) obtained in the comparative example was at a diffraction angle of 2θ=7.6±0.2°, 15.6±0.2°, 16.4±0.2°, 18.7±0.2. Characteristic diffraction peaks are shown at °, 19.0 ± 0.2 °, 20.5 ± 0.2 °, and 23.6 ± 0.2 °.

又,由於即使於高溫、減壓下進行乾燥,甲苯之殘量亦未減少,故而進行TG-DTA分析,確認是否為包藏體,結果如圖7所示,於甲苯之沸點以上之溫度即約139℃下重量開始減少,繼而於約150℃下觀測到吸熱波峰,因此支持本比較例中所獲得之上述式(1)所表示之具有茀骨架之醇為包藏體之情況。 In addition, since the residual amount of toluene was not reduced even at a high temperature and under reduced pressure, TG-DTA analysis was performed to confirm whether or not it was an inclusion body. As a result, as shown in Fig. 7, the temperature above the boiling point of toluene was about At 139 ° C, the weight began to decrease, and then an endothermic peak was observed at about 150 ° C. Therefore, the case where the alcohol having an anthracene skeleton represented by the above formula (1) obtained in the above Comparative Example was supported as an inclusion body was supported.

<比較例2> <Comparative Example 2>

向具備攪拌器、加熱冷卻器、及溫度計之玻璃製反應器中裝入上述式(2)所表示之具有茀骨架之酚化合物(9,9'-雙(4-羥基-3-苯基苯基)茀)30.0g(0.060mol)、碳酸乙二酯12.0g(0.136mol)、碳酸鉀0.7g(0.005mol)、及環己酮30.0g,於140℃下攪拌7小時,利用HPLC而確認原料波峰為1%以下。 A phenol compound having an anthracene skeleton represented by the above formula (2) (9,9'-bis(4-hydroxy-3-phenylbenzene) is charged into a glass reactor equipped with a stirrer, a heating cooler, and a thermometer. 30.0 g (0.060 mol), 12.0 g (0.136 mol) of ethylene carbonate, 0.7 g (0.005 mol) of potassium carbonate, and 30.0 g of cyclohexanone, and stirred at 140 ° C for 7 hours, and confirmed by HPLC. The peak of the raw material is 1% or less.

將所獲得之反應液冷卻至90℃後,加入環己酮23g、庚烷27g,將有機溶劑層保持於90℃,並水洗至洗浄水成為中性。水洗後,使用迪安-斯塔克裝置將所獲得之有機溶劑層於回流狀態下進行脫水,而獲得溶解有上述式(1)所表示之具有茀骨架之醇的晶析溶液。 After cooling the obtained reaction liquid to 90 ° C, 23 g of cyclohexanone and 27 g of heptane were added, and the organic solvent layer was kept at 90 ° C, and washed with water until the washing water became neutral. After washing with water, the obtained organic solvent layer was dehydrated under reflux using a Dean-Stark apparatus to obtain a crystallization solution in which the alcohol having an anthracene skeleton represented by the above formula (1) was dissolved.

其後,藉由冷卻至70℃,並於70℃下保溫1小時,而使結晶析出 後,於相同溫度下攪拌2小時。攪拌後,進而冷卻至19℃後,進行過濾,而獲得結晶。 Thereafter, the crystals were precipitated by cooling to 70 ° C and holding at 70 ° C for 1 hour. After that, it was stirred at the same temperature for 2 hours. After stirring, the mixture was further cooled to 19 ° C, and then filtered to obtain crystals.

將所獲得之結晶於內壓1.1kPa之減壓下、內溫90℃下乾燥3小時,但由於含有環己酮14重量%,故而將內溫升溫至110℃,於相同溫度下進而乾燥3小時,但環己酮含量仍為14重量%。 The obtained crystal was dried under an internal pressure of 1.1 kPa under reduced pressure at an internal temperature of 90 ° C for 3 hours. However, since 14% by weight of cyclohexanone was contained, the internal temperature was raised to 110 ° C and dried at the same temperature. Hour, but the cyclohexanone content was still 14% by weight.

所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

所獲得之結晶之重量:33.0g、HPLC純度:97.8%、環己酮含量:14重量%、DSC熔解吸熱最大溫度:114℃、鬆密度:0.4g/cm3The weight of the obtained crystal: 33.0 g, HPLC purity: 97.8%, cyclohexanone content: 14% by weight, DSC melting endothermic maximum temperature: 114 ° C, bulk density: 0.4 g/cm 3 .

又,由於即使於高溫、減壓下進行乾燥,環己酮之殘量亦未減少,故而進行TG-DTA分析,確認是否為包藏體。將TG-DTA之分析圖示於圖8。如該圖所示,因於約114℃下重量開始減少,並且於相同溫度下觀測到吸熱波峰,故而支持本比較例2中所獲得之上述式(1)所表示之具有茀骨架之醇為包藏體之情況。 Further, since the residual amount of cyclohexanone was not reduced even when dried at a high temperature and under reduced pressure, TG-DTA analysis was performed to confirm whether or not it was an inclusion. The analysis of TG-DTA is shown in Figure 8. As shown in the figure, since the weight starts to decrease at about 114 ° C and the endothermic peak is observed at the same temperature, the alcohol having the anthracene skeleton represented by the above formula (1) obtained in Comparative Example 2 is supported. The case of the inclusion.

<比較例3> <Comparative Example 3>

將規模設為10分之1,除此以外,利用日本專利特開2001-206863號之實施例6中所記載之方法進行裝入、反應,於65℃下攪拌了1小時之階段利用高速液體層析法分析反應液,但上述式(2)所表示之具有茀骨架之醇基本未生成,原料之9-茀酮殘留98%。因此,進而於相同溫度下繼續攪拌7小時,利用高速液體層析法分析反應液,但同樣地反應基本未進行,原料之9-茀酮殘留97%。 In addition to the above, the method described in Example 6 of JP-A-2001-206863 was used to carry out the reaction, and the mixture was stirred at 65 ° C for 1 hour to utilize a high-speed liquid. The reaction solution was analyzed by a chromatography method, but the alcohol having an anthracene skeleton represented by the above formula (2) was not substantially formed, and the 9-fluorenone of the starting material remained 98%. Therefore, the stirring was further continued at the same temperature for 7 hours, and the reaction liquid was analyzed by high-speed liquid chromatography. However, the reaction was not substantially carried out in the same manner, and the 9-fluorenone of the starting material remained 97%.

因此,基於日本專利特開2001-206863號〔0019〕之記載,將反應溫度自65℃變更為100℃,於相同溫度下繼續攪拌,結果至作為原 料之9-茀酮消失為止需要攪拌73小時。 Therefore, based on the description of Japanese Patent Laid-Open No. 2001-206863 [0019], the reaction temperature is changed from 65 ° C to 100 ° C, and stirring is continued at the same temperature, and the result is as the original. It takes 73 hours to stir until the 9-fluorenone disappears.

為了實施基於該文獻記載之後處理,將所獲得之反應液一分為二,向一者加入甲醇10g,向另一者加入異丙醇10g,加溫至60℃,繼續攪拌1小時後,分別加入純水30g,冷卻至30℃,但兩者均未析出結晶,分別獲得與水分離之焦油狀之液體。 In order to carry out the treatment based on the document, the obtained reaction liquid was divided into two, 10 g of methanol was added to one, and 10 g of isopropanol was added to the other, and the mixture was heated to 60 ° C, and stirring was continued for 1 hour, respectively. 30 g of pure water was added and the mixture was cooled to 30 ° C, but no crystals were precipitated in either of them, and a tar-like liquid separated from water was obtained.

<比較例4> <Comparative Example 4>

將9-茀酮之使用量設為18g,追加試驗日本專利特開2009-256342號之實施例4所記載之方法,而獲得上述式(1)所表示之具有茀骨架之醇20.7g(純度88.6%)。所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The amount of 9-fluorenone used was set to 18 g, and the method described in Example 4 of JP-A-2009-256342 was added to obtain 20.7 g of an alcohol having an anthracene skeleton represented by the above formula (1) (purity). 88.6%). The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

二甲苯含量:5.2重量%、YI值:46、DSC熔解吸熱最大溫度:146℃、鬆密度:0.3g/cm3Xylene content: 5.2% by weight, YI value: 46, DSC melting endothermic maximum temperature: 146 ° C, bulk density: 0.3 g / cm 3 .

將粉末X線之主要波峰(具有超過5%之相對強度者)示於表4。如表4所示,本比較例4中所獲得之包藏二甲苯之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=7.6±0.2°、15.6±0.2°、16.4±0.2°、18.7±0.2°、19.0±0.2°、20.5±0.2°及23.6±0.2°處顯示出特徵性繞射波峰。 The main peaks of the powder X-rays (having a relative strength of more than 5%) are shown in Table 4. As shown in Table 4, the alcohol having an anthracene skeleton represented by the above formula (1) obtained in Comparative Example 4 was at a diffraction angle of 2θ=7.6±0.2°, 15.6±0.2°, 16.4±0.2. Characteristic diffraction peaks are shown at °, 18.7 ± 0.2 °, 19.0 ± 0.2 °, 20.5 ± 0.2 °, and 23.6 ± 0.2 °.

<比較例5> <Comparative Example 5>

將9-茀酮之使用量設為9g,追加試驗日本專利特開2009-256342號之實施例2所記載之方法,而獲得上述式(1)所表示之具有茀骨架之醇13.5g(純度74.7%)。所獲得之上述式(1)所表示之具有茀骨架之醇之結晶之各分析值如下。 The amount of 9-fluorenone used was set to 9 g, and the method described in Example 2 of JP-A-2009-256342 was added to obtain 13.5 g of an alcohol having an anthracene skeleton represented by the above formula (1). 74.7%). The respective analysis values of the obtained crystal of the alcohol having an anthracene skeleton represented by the above formula (1) are as follows.

甲苯含量:3.0重量%、YI值:83、 DSC熔解吸熱最大溫度:126℃、鬆密度:0.2g/cm3Toluene content: 3.0% by weight, YI value: 83, DSC melting endothermic maximum temperature: 126 ° C, bulk density: 0.2 g/cm 3 .

將粉末X線之主要波峰(具有超過5%之相對強度者)示於表5。如表5所示,本比較例5中所獲得之包藏甲苯之上述式(1)所表示之具有茀骨架之醇於繞射角2θ=7.6±0.2°、15.6±0.2°、16.4±0.2°、18.7±0.2°、19.0±0.2°、20.5±0.2°及23.6±0.2°處顯示出特徵性繞射波峰。 The main peaks of the powder X-rays (having a relative strength of more than 5%) are shown in Table 5. As shown in Table 5, the alcohol having an anthracene skeleton represented by the above formula (1), which was obtained by the present invention, was obtained at the diffraction angles 2θ=7.6±0.2°, 15.6±0.2°, 16.4±0.2°. Characteristic diffraction peaks are shown at 18.7±0.2°, 19.0±0.2°, 20.5±0.2°, and 23.6±0.2°.

Claims (13)

一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為173~176℃之下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 173 to 176 ° C obtained by differential scanning calorimetry analysis, 一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=7.7±0.2°、17.2±0.2°、18.3±0.2°、19.6±0.2°、20.8±0.2°及21.4±0.2°處具有波峰的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=7.7±0.2°, 17.2±0.2°, 18.3±0.2°, 19.6. The following formula (1) having a peak at ±0.2°, 20.8±0.2°, and 21.4±0.2°, 一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為190~196℃之下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 190 to 196 ° C obtained by differential scanning calorimetry analysis, 一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=14.9±0.2°、17.8±0.2°、18.9±0.2°、19.7±0.2°、20.0±0.2°及21.0±0.2°處具有波峰的下述 式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=14.9±0.2°, 17.8±0.2°, 18.9±0.2°, 19.7 The following formula (1) having a peak at ±0.2°, 20.0±0.2°, and 21.0±0.2°, 一種具有茀骨架之醇之結晶,其係藉由示差掃描熱量分析所獲得之熔解吸熱最大溫度為167~170℃的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having a maximum melting endothermic temperature of 167 to 170 ° C obtained by differential scanning calorimetry analysis, 一種具有茀骨架之醇之結晶,其係於利用Cu-Kα線所獲得之粉末X線繞射圖譜中,於繞射角2θ=9.8±0.2°、14.9±0.2°、17.6±0.2°、18.8±0.2°、19.4±0.2°、20.0±0.2及20.6±0.2°處具有波峰的下述式(1)所表示者, A crystal of an alcohol having an anthracene skeleton, which is in a powder X-ray diffraction pattern obtained by using a Cu-Kα line, at a diffraction angle of 2θ=9.8±0.2°, 14.9±0.2°, 17.6±0.2°, 18.8. The following formula (1) having a peak at ±0.2°, 19.4±0.2°, 20.0±0.2, and 20.6±0.2°, 一種具有茀骨架之醇之結晶,其係於167~176℃之範圍中具有至少一個藉由示差掃描熱量分析所獲得之吸熱波峰的下述式(1)所表示者,[化7] A crystal of an alcohol having an anthracene skeleton, which is represented by the following formula (1) having at least one endothermic peak obtained by differential scanning calorimetry in the range of 167 to 176 ° C, [Chem. 7] 如請求項1至7中任一項之具有茀骨架之醇之結晶,其並非包藏體。 A crystal of an alcohol having an anthracene skeleton according to any one of claims 1 to 7, which is not an inclusion body. 如請求項1至7中任一項之具有茀骨架之醇之結晶,其中使上述式(1)所表示之具有茀骨架之醇12g溶解至純度為99重量%以上之N,N-二甲基甲醯胺30ml中而成之溶液之黃度(YI值)為10以下。 The crystal of an alcohol having an anthracene skeleton according to any one of claims 1 to 7, wherein 12 g of the alcohol having an anthracene skeleton represented by the above formula (1) is dissolved to an N,N-dimethyl group having a purity of 99% by weight or more. The yellowness (YI value) of the solution obtained in 30 ml of carbamide is 10 or less. 如請求項1至7中任一項之具有茀骨架之醇之結晶,其中芳香族烴類之含量為1重量%以下。 The crystal of an alcohol having an anthracene skeleton according to any one of claims 1 to 7, wherein the content of the aromatic hydrocarbon is 1% by weight or less. 一種如請求項1或2之具有茀骨架之醇之製造方法,其依序包括下述(a)~(c)之步驟:(a)於碳數為4以上之鏈狀酮類之存在下,使下述式(2): 所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟;(b)由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟;(c)於75~85℃下使結晶自上述晶析溶液析出,並將析出之結晶 分離之步驟。 A method for producing an alcohol having an anthracene skeleton according to claim 1 or 2, which comprises the following steps (a) to (c): (a) in the presence of a chain ketone having a carbon number of 4 or more Let the following formula (2): a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1); (b) preparing a carbon-containing material from the above reaction liquid a step of crystallization of a chain ketone of 4 or more and a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight; (c) crystallization from the crystallization solution at 75 to 85 ° C The step of separating and separating the precipitated crystals. 一種如請求項3或4之具有茀骨架之醇之製造方法,其依序包括下述(d)~(f)之步驟:(d)於碳數為4以上之鏈狀酮類之存在下,使下述式(2): 所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟;(e)由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟;(f)於90~100℃下使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟。 A method for producing an alcohol having an anthracene skeleton according to claim 3 or 4, which comprises the following steps (d) to (f): (d) in the presence of a chain ketone having a carbon number of 4 or more Let the following formula (2): a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1); (e) preparing a carbon-containing material from the above reaction liquid a step of crystallization of a chain ketone of 4 or more and a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight; (f) crystallization from the above crystallization solution at 90 to 100 ° C The step of separating and separating the precipitated crystals. 一種如請求項5或6之具有茀骨架之醇之製造方法,其依序包括下述(g)~(i)之步驟:(g)於碳數為4以上之鏈狀酮類之存在下,使下述式(2): 所表示之具有茀骨架之酚化合物與碳酸乙二酯進行反應,而獲得包含上述式(1)所表示之具有茀骨架之醇的反應液之步驟;(h)由上述反應液而製備含有碳數為4以上之鏈狀酮類且芳香族烴類及環狀酮類之合計含量未達10重量%之晶析溶液的步驟;(i)於70℃以下使結晶自上述晶析溶液析出,並將析出之結晶分離之步驟。 A method for producing an alcohol having an anthracene skeleton according to claim 5 or 6, which comprises the following steps (g) to (i): (g) in the presence of a chain ketone having a carbon number of 4 or more Let the following formula (2): a step of reacting a phenol compound having an anthracene skeleton with ethylene carbonate to obtain a reaction liquid containing an alcohol having an anthracene skeleton represented by the above formula (1); (h) preparing a carbon-containing material from the above reaction liquid a step of crystallization of a chain ketone of 4 or more and a total content of aromatic hydrocarbons and cyclic ketones of less than 10% by weight; (i) precipitation of crystals from the crystallization solution at 70 ° C or lower; And the step of separating the precipitated crystals.
TW105122933A 2015-07-21 2016-07-20 Crystal of alcohol with osmium skeleton and manufacturing method thereof TWI658034B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015-144187 2015-07-21
JP2015144187 2015-07-21
JP2016-089742 2016-04-27
JP2016089742 2016-04-27

Publications (2)

Publication Number Publication Date
TW201710231A true TW201710231A (en) 2017-03-16
TWI658034B TWI658034B (en) 2019-05-01

Family

ID=57833962

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105122933A TWI658034B (en) 2015-07-21 2016-07-20 Crystal of alcohol with osmium skeleton and manufacturing method thereof

Country Status (5)

Country Link
JP (1) JP6739137B2 (en)
KR (1) KR102614834B1 (en)
CN (2) CN107848933B (en)
TW (1) TWI658034B (en)
WO (1) WO2017014141A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI826527B (en) * 2018-09-19 2023-12-21 日商本州化學工業股份有限公司 Crystalline mixture of bisfluorene compounds

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI707839B (en) * 2016-05-30 2020-10-21 日商田岡化學工業股份有限公司 Manufacturing method of alcohols having fluorene skeleton
JP7379770B2 (en) * 2018-09-19 2023-11-15 本州化学工業株式会社 Crystalline form of bisfluorene compound
JP7134579B2 (en) * 2019-01-24 2022-09-12 田岡化学工業株式会社 Method for producing bisphenol compound having fluorene skeleton
JP2019108408A (en) * 2019-04-16 2019-07-04 田岡化学工業株式会社 Crystal of alcohol compound having fluorene skeleton and method for producing the same
CN114890877B (en) * 2022-01-28 2024-03-26 江苏永星化工股份有限公司 9, 9-bis [ 3-phenyl-4- (2-hydroxyethoxy) phenyl ] fluorene and preparation method thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2977714B2 (en) 1993-10-04 1999-11-15 鐘紡株式会社 Polyester molding
JPH09255609A (en) * 1996-03-21 1997-09-30 Taoka Chem Co Ltd Production of 9,9-bis(4-(2-hydroxyethoxy)phenyl)fluorene
JPH1045655A (en) * 1996-07-30 1998-02-17 Taoka Chem Co Ltd Production of fluorene derivative
JPH11158106A (en) * 1997-12-01 1999-06-15 Osaka Gas Co Ltd Production of 9,9-bis(4-(2-hydroxypropoxy)phenyl)fluorene
JP2001122828A (en) 1999-10-27 2001-05-08 Shinnakamura Kagaku Kogyo Kk Bifunctional (meth)acrylic ester composition and dihydric alcohol therefor
JP2001206863A (en) * 2000-01-25 2001-07-31 Osaka Gas Co Ltd Fluorene compound and method for the same
JP4671235B2 (en) * 2006-01-26 2011-04-13 田岡化学工業株式会社 Method for producing fluorene derivative
KR20090126260A (en) * 2007-02-15 2009-12-08 다오카가가쿠고교가부시키가이샤 Crystalline polymorph of fluorene derivative and process for production thereof
JP5588105B2 (en) * 2007-12-26 2014-09-10 大阪瓦斯株式会社 Bifunctional (meth) acrylate with fluorene skeleton
JP5325627B2 (en) * 2008-03-27 2013-10-23 大阪瓦斯株式会社 Method for producing alcohol having fluorene skeleton
JP5285561B2 (en) * 2009-09-30 2013-09-11 大阪瓦斯株式会社 Polyester resin having a fluorene skeleton
JP5501790B2 (en) * 2010-02-19 2014-05-28 大阪ガスケミカル株式会社 Polyester resin having a fluorene skeleton
JP5437106B2 (en) * 2010-02-19 2014-03-12 大阪ガスケミカル株式会社 Polyester resin having a fluorene skeleton
WO2013133106A1 (en) * 2012-03-09 2013-09-12 本州化学工業株式会社 Method for producing 9,9-bis(4-(2-hydroxyethoxy)phenyl)fluorene, crystal of said compound, and method for producing said crystal
JP6210555B2 (en) * 2014-04-03 2017-10-11 田岡化学工業株式会社 Method for recovering bisphenolfluorenes from a polyester resin having a fluorene structure
JP2016138071A (en) * 2015-01-29 2016-08-04 田岡化学工業株式会社 Method for producing bis hydroxyethyl ether of bisphenols

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI826527B (en) * 2018-09-19 2023-12-21 日商本州化學工業股份有限公司 Crystalline mixture of bisfluorene compounds

Also Published As

Publication number Publication date
KR20180030851A (en) 2018-03-26
TWI658034B (en) 2019-05-01
JP6739137B2 (en) 2020-08-12
JP2017200901A (en) 2017-11-09
KR102614834B1 (en) 2023-12-15
CN107848933A (en) 2018-03-27
WO2017014141A1 (en) 2017-01-26
CN107848933B (en) 2020-11-17
CN111848370A (en) 2020-10-30

Similar Documents

Publication Publication Date Title
TW201710231A (en) Crystal of alcohol having fluorene skeleton and method for producing same
TWI636038B (en) Crystal of alcohol having an anthracene skeleton and method for producing the same
JP2014227388A (en) Production method of binaphthalene compound
JP6830304B2 (en) Method for Purifying Dihydroxy Compound with Fluorene Skeleton
TWI740943B (en) Method for manufacturing alcohol compound having fluorene skeleton
JP6931984B2 (en) Crystals of alcohol compounds having a fluorene skeleton and methods for producing them
TWI707839B (en) Manufacturing method of alcohols having fluorene skeleton
JP6537388B2 (en) Inclusion compound using alcohols having a fluorene skeleton
JP7379770B2 (en) Crystalline form of bisfluorene compound
JP6994299B2 (en) A method for purifying a dihydroxy compound having a fluorene skeleton
JP7358696B2 (en) Crystalline mixture of bisfluorene compounds
WO2020004207A1 (en) Crystalline body of 9,9-bis(4-hydroxyphenyl)-2,3-benzofluorene
TW202344494A (en) Biphenanthrene compound or alkali metal salt thereof
JP2019108408A (en) Crystal of alcohol compound having fluorene skeleton and method for producing the same
JP2020158401A (en) Method for producing crystal of diol compound having fluorene skeleton